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Abstract 
 
Aims. The aim of this analysis was to provide comprehensive information on the access to 
and use of cardiac implantable electronic device (CIED) and catheter ablation therapy in 
the European Society of Cardiology (ESC) area. 
Methods. The European Heart Rhythm Association (EHRA) has been collecting 
descriptive and quantitative data on invasive arrhythmia therapies since 2008. This year 
50 of the 56 ESC member countries provided data for the EHRA White Book. Up-to-date 
information on procedure rates for the last five years together with information on 
demographics, economy, vital statistics, local healthcare systems and training activities 
are presented for each country and the five geographical ESC regions. 
Results. Our analysis indicated that considerable heterogeneity in the access to 
arrhythmia therapies still exist across the ESC area. In 2015, the CIED implantation rates 
per million population were highest in the Western followed by the Southern and Northern 
European countries. The catheter ablation activity was largest in the Western followed by 
the Northern and Southern areas. Overall, the procedure rates were 3-10 times higher in 
the European than in the non-European ESC countries. Economic resources were not the 
only driver for utilization of arrhythmia therapies as in some Eastern European countries 
with relative low gross domestic product the procedure rates exceeded the average 
values. 
Conclusion. These data will help the healthcare professional and stakeholders to identify 
and to understand in more depth the trends, disparities and gaps in cardiac arrhythmia 
care, and thereby promote harmonization of cardiac arrhythmias therapies in the ESC 
area. 
Keywords 
Pacemaker, Implantable cardioverter defibrillator (ICD), Cardiac resynchronisation 
pacemaker (CRT-P), Cardiac resynchronisation defibrillator (CRT-D), Catheter ablation, 
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Aims. The aim of this analysis was to provide comprehensive information on the 
access to and use of cardiac implantable electronic device (CIED) and catheter 
ablation therapy in the European Society of Cardiology (ESC) area. 
Methods. The European Heart Rhythm Association (EHRA) has been collecting 
descriptive and quantitative data on invasive arrhythmia therapies since 2008. This 
year 50 of the 56 ESC member countries provided data for the EHRA White Book. 
Up-to-date information on procedure rates for the last five years together with 
information on demographics, economy, vital statistics, local healthcare systems and 
training activities are presented for each country and the five geographical ESC 
regions. 
Results. Our analysis indicated that considerable heterogeneity in the access to 
arrhythmia therapies still exist across the ESC area. In 2015, the CIED implantation 
rates per million population were highest in the Western followed by the Southern 
and Northern European countries. The catheter ablation activity was largest in the 
Western followed by the Northern and Southern areas. Overall, the procedure rates 
were 3-10 times higher in the European than in the non-European ESC countries. 
Economic resources were not the only driver for utilization of arrhythmia therapies as 
in some Eastern European countries with relative low gross domestic product the 
procedure rates exceeded the average values. 
Conclusion. These data will help the healthcare professional and stakeholders to 
identify and to understand in more depth the trends, disparities and gaps in cardiac 
arrhythmia care, and thereby promote harmonization of cardiac arrhythmias 
therapies in the ESC area. 
Keywords 
Pacemaker, Implantable cardioverter defibrillator (ICD), Cardiac resynchronisation 
pacemaker (CRT-P), Cardiac resynchronisation defibrillator (CRT-D), Catheter 





The European Heart Rhythm Association (EHRA) White Book is the key source for 
information on invasive electrophysiological procedure rates in the European Society 
of Cardiology (ESC) member countries. EHRA has collected comprehensive 
information concerning the rates of invasive electrophysiology procedures alongside 
with information on demographics, economy, vital statistics and healthcare resources 
and reimbursements policies together with the National Cardiac Societies and 
Working Groups since 2008 (1). This year 50 of the 56 ESC member countries 
provided data for the EHRA White Book 2016 (2). These data have formed the 
backbone for the “ICD for life” (3) and many other strategic initiatives of the EHRA. 
 
Like in the past (4-7), the objective of this analysis is to provide up-to-date 
information on the rates of cardiac implantable electronic device (CIED) and catheter 
ablation procedures in the ESC countries over the past five years. In order to allow 
each country to view it´s data in a larger context and to facilitate detection of 
potential cross national disparities and gaps in the invasive electrophysiology 
procedure rates, the statistics for the four geographical European ESC regions and 
for the non-European ESC countries are presented separately (Figure 1). In addition, 
we have provided descriptive and quantitative information on the demographics and 
economic aspects as well as on training of electrophysiologist in the constituent ESC 
countries. 
 
The ability to see its own numbers in a European context provides each country 
robust means to demonstrate shortfalls in resource allocation, reimbursement and 
training requirements to the national or local authorities. It is our hope that these data 
will help to design national and international strategic initiatives and awareness 
activities to acquire more resources for cardiac arrhythmia management and 
eventually to champion EHRA´s mission “To improve the quality of life of the 
population by reducing the impact of cardiac rhythm disturbances and reduce 
sudden cardiac death”. 
 
  
Demographics and general societal and economic aspects 
In this section, we have provided an overview of the demographic and financial 
profile of the 56 ESC countries. The ESC countries are a heterogeneous group of 
nations with varying political, financial and demographic characteristics. Distribution 
of the population within these regions over the last five years is shown in Table 1. 
Vital statistics and gross domestic product 
Population and vital statistics and gross domestic product (GDP) in the 56 ESC 
countries are presented in Table 2. Total GDP ranged from 1.54 (San Marino) to 
3371 (Germany) billion US dollars (USD). The GDP per capita was almost 100 times 
higher in Luxembourg (103187 USD) than in Kyrgyzstan (1198 USD). 
 
Medium to high quality data on cause of death are available in most ESC countries, 
although they are lacking in many other parts of the world. World Health 
Organisation (WHO) health statistics reveal several important differences in the vital 
statistics between the ESC countries (8,9). As an example, the life expectancy at 
birth varied from 70.4 years (Kyrgyzstan and Moldova) to 83.2 years (San Marino). 
The death rate per 1000 population was lowest in Turkey (4.70%) and highest in 
Bulgaria (14.96%). It is noteworthy that in most countries with life expectancy over 
80 years, the GDP per capita is also relatively high (Table 2). 
Healthcare systems 
The organisation of healthcare across the ESC member countries varies markedly. 
Many countries provide national healthcare services with full coverage to the whole 
population while in others healthcare services are primarily delivered by commercial 
health insurance companies (Table 3). The proportion of people with no health 
insurance was highest in the Eastern European and non-European ESC countries. In 
the Northern, Southern and Western European ESC countries, patients do not need 
to provide any co-payment for invasive electrophysiology procedures, whereas in 
many Eastern European (e.g., Armenia, Bulgaria, and Georgia) and non-European 
ESC countries (e.g., Egypt and Morocco) a co-payment is necessary (Table 3). 
 
The number of hospitals and hospital beds available for healthcare are shown in 
Figure 2. The number of hospitals and beds were not directly related to the financial 
profile of the countries or to healthcare expenditure. Rather, these data indicate that 
some countries have directed more resources towards hospital care than ambulatory 
and home care. For example, the number of beds per 100.000 inhabitants was 828 
in Germany and only 259 in Sweden, despite the relatively high GDP and healthcare 
expenditure in both countries.  
Healthcare expenditure 
Healthcare expenditure has been escalating rapidly and nowadays represents the 
biggest government-spending item in many countries. In Figure 3 the healthcare 
expenditure is presented as percentage of the national GDP and in Figure 4 as 
expenditure per capita. The mean healthcare expenditure in the ESC area as 
percentage of the GPD was 8.3%. It was highest in the Netherlands (12.9%) and 
lowest in the Kazakhstan (4.3%). 
 
The healthcare expenditure per capita was highest in Norway (9692 USD) and 
Switzerland (9208 USD), and lowest in Kyrgyzstan (85 USD). Hence, there was 
more than 100-fold difference between the lowest and the highest healthcare 
expenditure per capita in the ESC area (8,9). Given the trend towards a progressive 
aging of populations and unhealthy living style, there is pressure to increase the 
healthcare expenditure. Despite this, the mean healthcare expenditure per capita in 
the ESC area was slightly lower in 2013 (2733 USD) than in 2011 (2818 USD). 
  
Certification of professional excellence 
General information 
In 2015, 47 countries (94% of the countries that responded to the EHRA White Book 
survey) provided data on certification of physicians and allied professionals in device 
therapy and invasive electrophysiology for the EHRA White Book 2016 (2). National 
certification program for CIED therapy and invasive cardiac electrophysiological 
procedures (EP) for physicians was available in 23 (46%) and 22 (44%) of these 
countries, respectively. A certification program was an obligatory practice 
requirement for CIED therapy in 11 countries and for EP in 12 countries, respectively 
(Figure 5 and 6). 
 
A national certification for allied professionals was available in 17 countries and was 
required for practice in 11 countries (Figure 7). Training centres were accredited in 
only 17 (34%) countries, and certification of training centres was mandatory in order 
to train fellows in 13 countries (Figure 8). Several centres in various regions were 
available as training centres for the EHRA Training Fellowship Program and allowed 
many young physicians from emerging economies to be trained in high volume 
centres abroad. 
EHRA certification 
The EHRA certification program is the first European certification of professional 
excellence in the field of CIED therapies and invasive electrophysiology. It plays an 
important role with regards to EHRA´s goal to promote unified and clear standards 
for the training of cardiac rhythm management specialists and to assure high quality 
in arrhythmia care across the ESC area. 
 
During the last five years 1276 physicians (767 in CIED and 509 in EP) from 58 
countries have participated in the EHRA examination. Over the years most of them 
have submitted the case logbook within the required time and subsequently 
achieved full (level 2) certification. In 2015, 294 physicians participated in the EHRA 
Certification Examination. The majority of them were male (78% in the invasive 
electrophysiology examination and 73% in the CIED program). Over the years, the 
proportion of female candidates has increased from less than 10% to about 25% 
(Figure 9). Last year the highest number of candidates participating in the CIED 
examination were from the Netherlands (31 candidates), Switzerland (23) and Italy 
(23). In the invasive electrophysiology examination, the highest numbers of 
participants were from Italy (13), Spain (12) and the Netherlands (12). 
 
In 2015 the pass rate was 67% for physicians participating in the invasive 
electrophysiology examination was and 62% for those participating in CIED 
examination. These numbers are markedly higher than in 2014 when the pass rate in 
the EP examination was 49% and in the CIED examination 51%. 
 
The EHRA certification program in cardiac device therapy for allied professionals 
was launched in 2011. Since then 215 allied professionals from 14 countries have 
participated in the EHRA examination and many of them have achieved full 
certification. Last year the pass rate in the allied professional exam was 67%, which 
was lower than in 2014 (74%). Last year most participants were from Italy (41). For 
allied professionals the examination is currently available in six languages (English, 




The 50 countries (89% of all ESC member countries) which submitted the requested 
data on PM implantation for this year´s edition of the EHRA White Book are listed in 
Table 4. Albania, Lebanon, Libya, Moldova, Syria and Tunisia did not provide any 
PM data this year. A national registry for PM implantations was present in 23 
countries, up three from the previous year (Table 4). The vast majority of implants 
were performed by cardiologists, and the remaining implantations were performed by 
physicians with various training backgrounds, including surgeons, 
anaesthesiologists, paediatricians, and internists. In three countries (Belarus, 
Slovenia, and Ukraine) the proportion of implanting cardiologists was less than 50% 
(Table 5).  
PM facilities and procedure rate 
It was reported that in 3660 centres, a total of 528441 PMs were implanted in 2015 
(Table 4) slightly up from last year. The mean number of centres implanting PMs per 
million inhabitants was 3.85 slightly higher than the preceding year (Figure 10). The 
country with the highest density of implanting facilities, excluding San Marino, was 
Germany (14.0 per million in habitants) followed by Luxembourg (10.5) and Belgium 
(9.2) Those with the lowest density were Egypt and Kyrgyzstan both with 0.4 per 
million and Morocco with 0.3 implanting centres per million inhabitants. 
 
In 2015, the mean PM implantation rate in the participating ESC countries was 518 
PM units per million inhabitants. The implantation rate was highest in Germany 
(1320), followed by Belgium (1154) and Finland (1063). The two countries with the 
lowest PM implantation rate were Armenia (38) and Kyrgyzstan (22). An overview of 
the PM implantation rate per million inhabitants for each country is shown in Figures 
11 and 12. Across the 50 countries, heterogeneity was observed in the distribution of 
PM implantation rate per million inhabitants, as has been seen in the White Book 
pacemaker data from previous years. 
 
The number of PM implantations according to the five ESC regions and the trend in 
implantation rate with comparison to the 28 European Union member countries (EU-
28) and the whole ESC area from 2011 to 2015 are shown in Figure 13. Countries 
with the highest and lowest activities in each region as well as yearly trends are 
shown in Figures 14-18. The number of PM implantations per million inhabitants was 
highest in Western Europe and lowest in Eastern Europe and in the non-European 
ESC countries. The most active countries in each region were Germany (1320 per 
million inhabitants), Finland (1063), Italy (1055), Czech Republic (843), and Israel 
(528), respectively. 
 
The change in the number of implanting centres from 2014 to 2015 is shown in Table 
6 and Figure 19 and the change in the number of PM implantations per million 
inhabitants during the same period is presented in Table 7 and Figure 20. The 
increase in the number of PM implantations was highest in those countries with 
rather small implantation numbers, Azerbaijan, Montenegro and Georgia, but 
interestingly there was an almost 15% increase in pacemaker implantation rates in 
Germany, the country with the highest implant rates in Europe. On the other hand, 
there was an almost 10% drop in the number of devices implanted in neighbouring 
Austria. The changes in the de novo PM implantation rate are shown separately in 
Figure 21 and for PM generator replacements in Figure 22. The relationship between 
the mean annual PM implantation rate per million inhabitants and the number of PM 
implanting centres per million inhabitants in the 56 ESC countries and in the EU28 is 
shown in Figure 23. 
 
Leadless pacing 
Leadless pacing is new therapeutic modality (10,11) which has just been introduced 
in most ESC countries. This is the first time that data on leadless pacemaker 
implantations has been collected for the EHRA White Book. According to the EHRA 
White Book survey a total of 244 leadless pacemakers were implanted in nine 
countries in 2015. No leadless pacemakers were implanted in 23 countries, and data 
on these devices were not available from 24 ESC countries. The most active 
countries in the ESC area with regards to leadless pacemaker implantations were 
France, the Netherlands and Hungary, but the implantation rates were rather low 
also in these early adopters (Figure 24). 
 
Implantable Cardioverter Defibrillators (ICD) 
General information 
The 50 countries (89%) which submitted data for the EHRA White Book on ICDs in 
2015 are listed in Table 8. Albania, Lebanon, Libya, Moldova, Syria and Tunisia did 
not provide data on ICD implantations, while Sweden provided only limited data. In 
25 countries, a national registry for ICD implantations was in use. The vast majority 
of implants were performed by cardiologists, and the remaining implantations were 
performed by physicians having various other training backgrounds, mainly surgical. 
However, in some countries (Austria, Belarus, and Ukraine), the proportion of 
implanting cardiologists was less than 50% (Table 5). 
ICD facilities and procedure rates 
It was reported that in 2266 national centres, a total of 103399 ICDs were implanted 
in 2015 (Table 8), an almost 2% increase from 2014. Table 8 also shows a 
comparison to the previous four years in each country. As shown in Figure 25 the 
mean number of implanting centres in the ESC area was 2.38 per country. In the 
ESC area the mean number of ICD implantations per million inhabitants in 2015 was 
102. In Figures 26 and 27 the ESC countries are grouped into quartiles according to 
the number of ICD implantations per million inhabitants. Germany (358 per million 
inhabitants) had by far the highest implant rate followed by San Marino (242), Italy 
(238), and Norway (233). The lowest reported implant rate was in Ukraine (1 per 
million inhabitants). 
 
The number of ICD implantations according to the five ESC regions and the trend 
from 2011 to 2015, compared to the EU28 and the whole ESC area, is shown in 
Figure 28. In Western Europe (294) the number of ICD implantations per million 
inhabitants was almost twice higher than in any other ESC region. ICD implantation 
rate also exceed 100 per million population in the Southern (159) and Northern (123) 
European regions. The top and bottom three countries within the five ESC region are 
shown in Figures 29-33. The most active countries in each region were Germany 
(358 per million inhabitants) in the west, Norway (233) in the north, Poland (221) in 
the east, San Marino (242) and Italy (238) in the south and Israel (162) in the non-
European ESC region. 
 
The changes in the number of implanting centres from to 2014 to 2015 are shown in 
Table 9 and Figure 34 and the change in the number of ICD implantations per million 
inhabitants during the same period is presented in Table 10 and Figure 35. These 
numbers are divided into de novo implantations and ICD generator replacements in 
Figures 36 and 37. 
 
The relationship between the annual ICD implantation rate per million inhabitants 
and the number of ICD implanting centres per million inhabitants in the EU28 
countries and the ESC area are shown in Figure 38. 
 
Subcutaneous ICD implantations 
Subcutaneous ICD (S-ICD) is a novel therapeutic modality for prevention of sudden 
cardiac death. The device is implanted entirely under the skin avoiding the need for 
intravascular leads. It is best suited for patients with no need for pacing and 
increased risk for transvenous lead complications (12,13). 
This is the first time that data on S-ICD implantations has been collected for the 
EHRA White Book. As with the other new therapies and procedures the response 
rate for this question in the EHRA White Book survey was markedly lower than that 
of the conventional arrhythmia treatments. A total of 1049 S-ICDs were implanted in 
13 countries in 2015. No S-ICDs were implanted in 24 countries, and 19 countries 
reported no data on these devices. The most active countries with regards to the S-
ICD implantations were Italy with 561 implantations followed by the United Kingdom 
(196 implantations) and the Netherlands (150 implantations) (Figure 39). 
 
Cardiac Resynchronization Therapy devices (CRT) 
General information 
The 49 (87.5%) countries, which submitted data on cardiac resynchronization 
therapy (CRT) for the EHRA White Book 2016, are listed in Table 11. Albania, 
Kyrgyzstan, Lebanon, Libya, Moldova, Syria and Tunisia did not report any data 
related to CRT therapy. The vast majority of implants were performed by 
cardiologists (Table 5), and the remaining implantations were performed by 
physicians having various other training backgrounds, mainly surgeons. In Belarus, 
however, all CRT implantations were done by surgeons and the majority of CRT 
implantations in the Ukraine and Russia were likewise done by others than 
cardiologists (Table 5). 
CRT facilities and procedure rates 
It was reported that in 2015 a total of 84205 CRT devices were implanted in 1527 
national centres (Table 11). There was an increase in both absolute numbers of 
implants and the rate of implants per million inhabitants compared to 2014, but a fall 
in the number of implanting centres (Table 11). The number of CRT implanting 
centres per million inhabitants in the ESC countries is shown in Figure 40. The mean 
number of implanting centres was 1.68 per country, which is a decrease from the 
previous year. The mean number of CRT devices implanted in 2015 was 82. 
Germany (261 implants per million), Italy (207) and the Czech Republic (183) had 
the highest number of implants of all CRT devices. Implantation rates with the 
countries divided into quartiles are shown as a bar graph in Figure 41 and as a 
geographical map in Figure 42.  
 
Figures 43 and 44 show the corresponding numbers for CRT pacemakers (CRT-P) 
and CRT defibrillators (CRT-D). The ratio of CRT-D/CRT-P implants was 2.77 with a 
mean of 61 CRT-Ds and 22 CRT-Ps per million inhabitants. The ratio between CRT-
D and CRT-P is slightly higher than last year representing a continuation in the trend 
that the growth in CRT-D use is more than CRT-P´s, while there is nevertheless an 
increase in the use of both types. Denmark had the highest rate of CRT-P 
implantations followed by the United Kingdom (Figure 43) while CRT-D implantation 
rate was highest in Germany followed by Italy and Israel (Figure 44). 
 
The use of CRT devices within the five geographical ESC regions is shown in Figure 
45 and further data from within each region are shown in Figures 46-50, respectively. 
The most active countries within each region were Germany (261 per million 
inhabitants), Denmark (176), the Czech Republic (183), Italy (207) and Israel (180), 
respectively. 
 
The changes in the number of implanting centres per million inhabitants between 
2014 and 2015 are shown in Table 12 and Figure 51. The changes between 2014 
and 2015 for the number of total CRT implantations are shown in Table 13 and 
Figure 52 and the change according to CRT device type are shown in Figures 53 
and 54. 
 
The relationship between the annual CRT implantation rate and the number of CRT 
implanting centres per million population in the EU28 countries and the ESC area is 




This was the fourth year that information on lead extractions (LE) was included in the 
EHRA White Book. The number of countries submitting data on LE procedures is not 
as high as for pacemakers and ICDs (Table 14). Seventeen countries did not submit 
any data on lead extractions and four submitted incomplete data. In most countries 
the primary operators in LE procedures were cardiologists. 
Lead extraction facilities and procedure rates 
A total of 8748 LE procedures (Table 14) were performed in 326 LE centres in 2015. 
The mean number of lead extractions was 12.8 per million, but this needs to be put 
into context with large number of missing data (Figure 56). It has been suggested 
that in an active centre the minimum annual number of LE should be at least 15 per 
million inhabitants (14-15). Assuming that each centre treated an equivalent number 
of patients it can be extrapolated that in the numbers for LE per centre in 2015 were 
lower than recommended in most of the countries. The mean number of LE was 
highest in France (45.1 per million population) followed by Norway (37.3) and 
Germany (29.2) (Figure 56). Due to missing or incomplete data and a very low LE 





A total of 46 countries (82% of the ESC countries) submitted data on catheter 
ablation facilities and procedures to the EHRA White Book (Table 15). Sixteen had a 
national registry on catheter ablation and in the remainder the numbers originated 
from a survey or an estimate by the national working groups. In 2015 a total of 
1077305324 people lived in the ESC countries. After excluding those countries that 
did not report the number of ablations or ablation centres, the population covered by 
the EHRA White Book for ablation procedures was 967796331 (about 90% 
coverage), which is about the same in the previous year. Like in previous years a 
major problem in 2015 was that no ablation data was received from Italy, which is 
known to have well developed ablation programs. 
Catheter ablation facilities and procedure rates 
In 2015 the total number of ablation centres in the countries which submitted data for 
the EHRA White Book was 1159 (Table 15), and the mean number of ablation 
centres per million population was 1.34 (Figure 57). The changes in the number of 
ablation centres from 2014 to 2015 are shown in Table 16 and Figure 58. 
 
The total number of catheter ablations in the ESC area in 2015 was 243808 (Table 
15), which was about 3% more than that reported in 2014 (235793). The mean 
number of ablations done per million population was also slightly higher in 2015 
(259) than in 2014 (244). 
 
The number of catheter ablations per million inhabitants is shown in Figures 59 and 
60. In these figures the ESC countries are grouped in quartiles according to their 
ablation activities. As in previous years, most countries in the top quartile were from 
Northern and Western Europe. ESC countries outside Europe had low ablation 
activity and they are mostly found in the lowest (1st) quartile. Eastern European 
countries had a heterogeneous distribution, which spanned over all four quartiles. 
Data on the number of catheter ablations during the last five years are shown in 
Table 15, and detailed information on the changes in the number of ablation 
procedures from 2014 to 2015 is presented in Table 17 and Figure 61. The mean 
number of ablations performed per centre was almost exactly the same in 2015 
(259) as in 2014 (260) indicating the ablation activities in the centres that reported 
their numbers were constant. The relationship between the annual catheter ablation 
rate and the number of ablation centres per million population in the EU28 countries 
and the whole ESC area is shown in Figure 62. 
 
More detailed data on ablation activity in the five geographical ESC regions are 
presented in Figure 63. The mean number of ablations per million inhabitants was 
higher in the Western than in the other European regions and in the non-European 
ESC countries. In the non-European ESC countries catheter ablation rate was 
almost thirty times lower than in the European ESC countries (13 vs. 310 per million 
population). In 2015, the most active countries were Germany, Denmark and 
Switzerland with 789 and 703, 703 ablations per million population, respectively 
(Table 15 and Figure 59). In San Marino, no ablations were performed. 
 
Data for the last 5 years from the three most active and three least active countries 
in the different ESC regions are presented in Figures 64-68. The most active 
countries in the Northern, Western, Southern and Eastern Europe were Denmark 
(703 ablations per million inhabitants), Germany (789), Slovenia (359) and Czech 
Republic (578), respectively. Among the non-European ESC countries Kazakhstan 
was the most active with 136 catheter ablations per million population. In 2015 the 
rate of ablations per million population increased in most of the ESC countries, but 
Cyprus, Armenia and Morocco reported more than 50% decrease in catheter 
ablation activities. The growth in the mean ablation rate per million population was 
highest in the Eastern and Southern European region. In Slovenia, the increase in 
ablation rate was 63%. 
Atrial fibrillation ablation rates 
In 2015 a total of 87527 atrial fibrillation (AF) ablations were performed in the 43 
ESC countries that submitted AF ablation data for the EHRA White Book (Table 18). 
In Figures 69 and 70 countries performing AF ablations are grouped in quartiles 
according to their activity. The mean number of AF ablations per million inhabitants 
was 96, which is about the same as in 2014 (96 per million). The most active 
countries were Germany (416 AF ablations per million population), Denmark (337) 
and Belgium (289). Like 2014 most countries in the top quartile were from the 
Northern and Western European region, and the countries with the lowest activity (1st 
and 2nd quartiles) were mainly from Southern Europe and from the non-European 
ESC region. In the Eastern region the AF ablations activity was extremely 
heterogeneous. The growth in AF ablation rate per million population was highest in 
Azerbaijan (197%), Turkey (87%) and Bulgaria (79%), whereas in Armenia, Cyprus 
and Serbia the AF ablation rate decreased by 91%, 81 % and 36%, respectively 
(Table 19 and Figure 70). In Algeria, Bosnia & Herzegovina, Malta and San Marino 
no AF ablations were performed in 2015. 
 
Detailed data on AF ablation activities in the five ESC regions and a comparison to 
the corresponding numbers in the ESC and EU28 countries are presented in Figure 
72. The rate of AF ablations was markedly lower in the non-European countries than 
in the European ESC countries (8 vs. 125 per million population). The most active 
countries in the Northern, Western, Southern and Eastern European region, and 
among the non-European ESC countries were Denmark (337 AF ablation per million 
population), Germany (416), Slovenia (108), the Czech Republic (238) and 
Kazakhstan (42), respectively (Figures 73-77). The proportion of AF ablations out of 
the total number of ablations varied between 1.5% in Azerbaijan to 52.7% in 
Germany. The mean ratio of AF ablations out of total ablations was 35.7%, and the 
proportion of AF ablations compared to all ablations was more than 40% in seven 
countries (Figure 78). 
Ventricular tachyarrhythmia ablation rates 
In 2015 the number of centres performing more than 10 ventricular tachyarrhythmia 
ablations for patients with structural heart disease per million population was highest 
in Germany (1.71) and lowest in Ukraine (0.02) (Figure 79). Data on ventricular 
tachyarrhythmia ablations in patients with structural heart disease were collected for 
the second time in 2015. A total of 35 (63%) countries reported data on ventricular 
tachycardia (VT) or ventricular fibrillation (VF) ablations. The mean number of VT/VF 
ablations per million population in the ESC countries had increased from 9.2 in 2014 
to 16.0 in 2015. It was highest in Germany (83 per million population) followed by 
Finland (30), the Czech Republic (28) and Denmark (26) (Figure 80 and 81). Many 
countries did not report any data on VT/VF ablation (n=21) or did not perform any 
VT/VF ablations (n=5) in 2015. 
Percutaneous left atrial appendage closures 
During recent years percutaneous left atrial appendage (LAA) closure has become 
an attractive option to prevent AF related thromboembolic complications among 
patients with high risk of bleeding and contraindications to oral anticoagulation 
therapy (16,17). The mean number of centres performing LAA closures in the ESC 
area was 0.9 per million population (Figure 82). In 2015, however, only 26 of the 56 
ESC member countries (46%) submitted the requested data on the numbers of LAA 
closures for the EHRA White Book. The mean number of procedures in the ESC 
countries performing LAA closures was the same in 2015 as in 2014 (8.9 per million 
inhabitants). Germany was by far the most active country (54.8 LAA closure per 
million inhabitants) followed by Finland (22.5) and Latvia (14.1) (Figure 83). Of note 
is that in Kazakhstan, where the CIED implantation and catheter ablations numbers 
were generally quite low, 4.5 LAA occlusions were performed per million inhabitants. 
 
Discussion 
For almost a decade, the EHRA White Book has been a key resource for health care 
professionals and stakeholders with an interest in the advancement of cardiac 
arrhythmia therapies in Europe. It has already played an important role in the ICD for 
life program (3) and many other strategic initiatives and awareness activities of the 
EHRA. Current analysis of the EHRA White Book data showed that considerable 
variations in access to and use of invasive electrophysiological procedures continue 
to exist within the ESC area. Despite several improvements over the last 5 years, 
there is still a clear need to improve the availability of invasive procedures for 
complex arrhythmias in many ESC countries. 
 
As in previous years, the mean CIED implantation rates were markedly lower in the 
Eastern European and non-European ESC countries than in the other regions. The 
catheter ablation activity was substantially higher in the Western and Northern 
European than in the non-European ESC countries. The Eastern European ESC 
countries were characterized by large variations in the procedure rates, with 
numbers spanning over all four quartiles of the activity distribution. Surprisingly there 
was a drop in the number of lead extractions between 2014 and 2015 although 
continued increase in numbers was expected. The reasons for this are unclear, and 
it cannot be excluded that this was related to a reporting bias. 
Potential explanations for the disparities between the ESC countries 
As shown in Figure 3 the healthcare expenditure currently absorbs from 4.3 to 12.9% 
of GDP in the ESC countries. Hence, it is not surprising that there continues to be a 
large gap between the EU28 countries and selected Eastern European and non-
European ESC countries in the CIED implantation facilities and rates. Likewise, 
catheter ablation facilities and rates were markedly lower in the non-European than 
in the European ESC member countries. 
 
Data on health expenditures and CIED implantation rate per capita indicate that a 
low proportion of healthcare expenditure is, as would be expected, associated with a 
lower use of device therapy and the use of complex interventional electrophysiology 
procedures (Figure 83). However, in some Eastern European countries with 
relatively low GDP, device implantation and catheter ablation rates per million 
population exceed those of certain Western and Northern European countries. Good 
examples of this are the Czech Republic and Hungary, which were in the most active 
quartile for CRT therapy and AF ablations. Furthermore, despite the economic 
difficulties all across Europe in the past 7-8 years, the use of device and catheter 
ablation therapies has been growing in a number of countries with relatively low 
GDP. On the other hand, in many Western and Northern European countries with 
high GDP the use of device and ablation therapies has remained stable or even in 
some cases declined slightly. It is unclear whether this is a consequence of 
constraints on healthcare expenditure in the wake of the financial crisis or if that 
supply has already met the demand or both. Nevertheless, these data indicate that 
relatively high GDP is not the only explanation for early adaptation of novel 
healthcare innovations with relatively high initial cost. Other potential excuses for the 
observed disparity include lack of manpower, training, facilities and likely low referral 
rates (18). A personal co-payment for the procedures may limit access to CIED and 
catheter ablation therapies in countries not providing full coverage for the whole 
population. 
Impact of the economic crisis 
In recent years a clear limitation for improvements in arrhythmia management across 
the ESC area has been a difficult economic situation. Due to the ongoing financial 
problems many countries have made substantial budget cuts for healthcare (18-22). 
At the same time the number of elderly people requiring vast medical and social care 
has grown rapidly. In this context, socioeconomic disparities pose a major threat to 
healthcare systems, and may limit the use of innovative technologies such as ICD 
therapy for primary prevention of sudden cardiac death and catheter ablation of AF 
and VT/VF, unless the effectiveness and efficacy of the healthcare system is 
improved (18-22). 
 
The cost of health and social care is escalating not only due to population aging and 
costly developments in the medical technology ﬁeld but also as a result of unhealthy 
life styles, higher expectations for better services, unit cost inﬂation, inefﬁciency, and 
suboptimal use of resources. Therefore, we need an integrated and comprehensive 
approach to improve patient access arrhythmia care. With regards to this it was 
interesting to note that the number of hospitals and beds were not directly related to 
the financial profile or healthcare expenditure of a given country. Rather, some 
countries have directed more resources towards hospital care than ambulatory and 
home care. 
Evolving areas in cardiac arrhythmia therapy 
Most of the innovative medical technologies have a high initial cost. Therefore, their 
efficacy and safety needs to be proven before they can reach wide acceptance and 
clinical use. Evolving areas in the cardiac arrhythmia therapy include leadless 
pacing, subcutaneous ICD therapy, use of percutaneous LAA occlusion devices for 
prevention of thromboembolic complications in patients with atrial fibrillation and 
catheter ablation of complex atrial and ventricular tachyarrhythmias. The main 
problem in analysing the current access and use of the evolving arrhythmia therapies 
was that many countries did not report data on these developing therapies. 
Leadless pacing has recently been introduced in most ESC countries. The most 
active countries in the ESC area with regards to leadless pacemaker implantations 
were France and the Netherlands, which were active also in the studies evaluating 
the safety and efficacy of this therapy (10). Although the overall implantation rates 
were rather low also in these early adopters, leadless pacing is expected to grow 
rapidly. 
The results of numerous randomized, multicentre trials have established the role of 
traditional ICD therapy in secondary and primary prevention of sudden cardiac death 
(23). However, transvenous ICD leads have significant short- and long-term 
complications, offsetting some of the benefit of this therapy. This has led to the 
development of the entirely subcutaneous ICD (12,13). This was the first year that 
the White Book questionnaire asked about S-ICD implantation. Italy reported by far 
the highest implantation rate for these devices. Obviously, the limited data do not 
allow for much interpretation but the plan is to continue to gather data in coming 
years on this emerging procedure. 
According to the White Book data the role of catheter ablation in treatment of 
symptomatic AF is well established in Western and Northern Europe and in some 
countries in Southern and Eastern Europe, whereas in the non-European ESC 
countries the access to AF ablation is limited. Catheter ablation of VT has been one 
of the key areas of growth in electrophysiology in recent years. The growing need for 
VT/VF ablations in patients with structural heart disease (23-25) was reflected in the 
White Book data where the number of VT/VF ablation procedures per million 
inhabitants increased from 9.2 in 2014 to 16.0 in 2015. 
 
Another important evolving area in cardiac rhythm management is the use of 
percutaneous LAA closure devices to prevent AF related thromboembolic 
complications (16,17). According to a recent meta-analysis, LAA occlusion is non-
inferior to warfarin in patients at high risk of thromboembolic and bleeding events 
(16). As with VT/VF ablations, the number reported for LAA occlusion have grown 
significantly within the last two years. The number of LAA occlusion was largest in 
Germany, but interestingly many of the countries in the top ten were from Eastern 
Europe. 
The role of European Heart Rhythm Association 
EHRA has collected information on the resources and characteristics of procedures 
performed throughout the ESC area in the field of cardiac arrhythmias for almost a 
decade. The White Book data have formed a backbone for many national and cross-
national strategic initiatives and awareness activities such as the “ICD for life” 
campaign. 
 
Disparity in the implementation of arrhythmia treatment and practice guidelines is 
likely to continue, unless there is an improved investment in the infrastructure. This 
includes electrophysiology laboratories, specialized equipment, and not least 
improved training opportunities. Likewise, standardization of training requirements 
and implementation of current clinical practice guidelines are important steps. EHRA 
has been very active in promoting unified standards for training of cardiac rhythm 
management specialists and to try to assure high quality in arrhythmia care in a 
broad sense. The ongoing White Book project has revealed important disparities in 
this field also and provided a solid base to improve and align arrhythmia 
management strategies across ESC countries. The ability to see its own numbers in 
a European context provides each country robust means to demonstrate shortfalls in 
resource allocation, reimbursement and training requirements to the national or local 
authorities, and to make recommendations to improve decision and policymaking 
concerning the cardiac arrhythmia care ﬁeld at national and cross-national level. 
 
The EHRA certification program provides an excellent platform to improve and 
harmonize the training and the level of arrhythmia care in the ESC area. The 
introduction of the EHRA accreditation program for teaching centres will provide 
further support to standardization of training. EHRA fellowship grants have already 
allowed many junior physicians from countries with low procedure rates to receive 
training in high volume centres across the ESC area. The number of applications for 
the EHRA Fellowship grants has been increasing steadily and the certification 
program is now available for allied professionals. Last year the EHRA Training 
Fellowship committee awarded 10 grants for young physicians. In addition, a specific 
proctor programme was recently launched in order to provide further education in the 
field of cardiac arrhythmia management. 
 
In summary, the EHRA White Book data indicate that there are still significant 
differences in training and certification requirements between the ESC countries. 
Accordingly, there is a need to involve more physicians and allied professionals in 
the EHRA certification system to assure uniform and high level theoretical and 
practical training for all healthcare professionals, regardless of their country of origin. 
Limitations 
There are several limitations in the methodology of the EHRA White Book data 
collection. Data collection is exclusively based on voluntary activity of the National 
Cardiac Societies or Arrhythmia Working Groups. This year 50 out of the 56 ESC 
nations responded to the White Book questionnaire. Some countries, on the other 
hand, have never reported data for the White Book and many countries reported 
incomplete data. In particular, many countries did not provide data on new therapies 
like leadless pacing, S-ICD and VT/VF ablations. This may be related to incomplete 
collection of data on these procedures, which are relatively new and performed only 
in few select centres. 
 
With regard to the analysis and interpretation of summary data it was a major 
drawback that Italy, one the most populated countries in the ESC area, once again, 
did not submit any data on catheter ablations. In addition, there were large variations 
in national data sources. About 50% of the data came from national registries (20 
countries) and the other half was based on surveys and other estimates conducted 
by the National Societies. This is relevant since the coverage of the registries in 
some of the ESC countries is relatively poor and many procedures are not included 
in the registry data. In contrast, surveys and other estimates may overestimate the 
procedure numbers. The lack of a national quality control institution in many 
countries (Figure 85) also reflects the need for centralized data collection and quality 
assurance. 
 
Comparison of results between nations or regions can be a major driver in leading to 
changes within health systems. Therefore, for the third year in row the data were 
presented separately for the five geographical regions within the ESC area. In order 
to avoid any economic, political or historical bias the European regions were 
composed according to the United Nations Statistics Division and all other ESC 
countries were included in the non-European ESC region. This classification is not 
free of limitations. Nevertheless, we feel that as a well-defined and widely accepted 
geographical classification the UN grouping provides a neutral platform for regional 
comparisons within the ESC area. 
Future directions of the EHRA White Book project 
The goal is to continue to improve the reliability of the EHRA White Book data and to 
ensure the quality of the collected data. In this regard, it is important that the national 
registries continue to develop and that their coverage expand in the future. We also 
encourage the adoption of such a registry if not already present. 
 
Next year we will celebrate the 10-year anniversary of the EHRA White Book data 
collection. Our goal is, together with the National Cardiac Societies and Working 
Groups, to recheck the prior data and to complete the missing values in the dataset 
before the end of this year. All National Societies will receive a copy of the previously 
reported data after the ESC Congress and we hope to get the updated data within a 
couple of months after that. Collection of the 2016 data will be launched as 
previously in February 2017. We hope to reach 100% coverage for the anniversary 
edition of the White Book. 
 
An attractive long-term goal with regards to the data collection and analysis is to 
develop an internet-based electronic database, which would allow free comparisons 
between and within the ESC countries. Such a database would also provide a 
unique future platform for online multicentre registry based clinical trials in arrhythmia 
therapy (26). The ESC recently launched the Atlas on Cardiology project (27) with 
similar goals as the White Book. The Atlas will provide descriptive and quantitative 
information on economy, demographics, health system and health policies alongside 
data concerning health care resources and a wide range of cardiology interventions 
in the ESC member countries. There are currently no plans to discontinue the White 
Book, but eventually it is possible that these two projects will merge. 
Conclusions 
During the past nine years the White Book has developed into a substantial asset 
not only for the cardiac electrophysiology community but also for healthcare 
administrators and politicians in the ESC area. The availability of up-to-date 
information is critical to those facing the challenge of balancing healthcare budgets 
and allocating limited resources. The statistics presented herein show that, despite 
significant improvements in many areas of arrhythmia care, there still is considerable 
heterogeneity in the availability of invasive arrhythmia therapies across the ESC 
area. Reducing this gap continues to be one of the main goals of the EHRA. 
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Figure 1. Geographic representation of the 56 European Society of Cardiology (ESC) 
countries. The European regions were composed according to the UN Statistics Division 
(http://unstats.un.org/unsd/methods/m49/m49regin.htm).
Figure















































































































































































































































































































































































































































Figure 3. Healthcare expenditure as percentage of national gross domestic product (GDP) in 































































































Figure 4. Healthcare expenditure per capita in the ESC countries in 2013. Mean number of
expenditure is weighted by population.
Figure 5. Certification for cardiac implantable electronic device (CIED) therapy in the ESC 
countries in 2015.
No answer = 3 countries
No = 24 countries
Yes, but it´s not required for practice = 12 countries
Yes, it´s required for practice = 11 countries
Figure 6. Certification for invasive electrophysiology in the ESC countries in 2015.
No answer = 3 countries
No = 25 countries
Yes, but it´s not required for practice = 10 countries
Yes, it´s required for practice = 12 countries
Figure 7. Certification for allied professionals in the ESC countries in 2015.
No answer = 3 countries
No = 30 countries
Yes, but it´s not required for practice = 6 countries
Yes, it´s required for practice = 11 countries
Figure 8. Certification for training centres in the ESC countries in 2015.
No answer = 4 countries
No = 29 countries
Yes, but it´s not required for practice = 4 countries
Yes, it´s required for practice = 13 countries
Figure 9. Number of participants in the European Heart Rhythm Association (EHRA) 
examination during the last five years. CIED, cardiac implantable electronic device.
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Figure 10. Number of pacemaker (PM) implanting centres per million inhabitants in the ESC 


































































































Figure 11. Pacemaker implantations per million inhabitants in the ESC countries in 2015. the 


















































Median number PM implantations = 623


















































518 = Ø PM implantations per million 
inhabitants (weighted by population)
1st quartile ≥ 22 ≤ 221
2nd quartile > 221 ≤ 623
3rd quartile > 623 ≤ 817
4th quartile > 817 ≤ 1320
Figure 12. Pacemaker implantations per million inhabitants in the ESC countries in 2015. The 
mean number of implantations is weighted by population.
518 = Ø  PM implantations per million 
inhabitants (weighted by population)
1st quartile ≥ 22 ≤ 221
2nd quartile > 221 ≤ 623
3rd quartile > 623 ≤ 817





















Figure 13. Pacemaker implantations per million inhabitants 2011-2015 in the five 
geographical regions of the ESC and comparison to the total ESC area and the 28 member 
countries of the European Union (EU28).
Northern Europe Western Europe




































































20122011 2013 2014 2015
*




2012 2013 2014 20152011
TOP 3 













































FYR Macedonia Bosnia and Herzegovina







Non-European ESC countries 
Israel
528537515558500





















Figure 18. Pacemaker implantations per million inhabitants 2011-2015 in the
non-ESC countries. *No data available
* *






















































































































































































































































































































































































































































































Figure 22. Change in the number of pacemaker replacements per million inhabitants from 
































































































































Figure 23. Pacemaker implantation centres and rates in the ESC and European Union (EU28) 
member countries in 2015. Bubble size is related to population in the country. The ISO codes of 
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Figure 25. Implantable cardioverter-defibrillator (ICD) implanting centres per million 


































































































Figure 26. Implantable cardioverter-defibrillator implantations per million inhabitants 

































































































102 = Ø ICD implantations per million 
inhabitants (weighted by population)
1st quartile ≥ 1 ≤ 20
2nd quartile > 20 ≤ 93
3rd quartile > 93 ≤ 161
4th quartile > 161 ≤ 358
Figure 27. Implantable cardioverter-defibrillator implantations in the ESC countries in 
2015. 
102 = Ø ICD implantations per million 
inhabitants (weighted by population)
1st quartile ≥ 1 ≤ 20
2nd quartile > 20 ≤ 93
3rd quartile > 93 ≤ 161

















Figure 28. Implantable cardioverter-defibrillator implantations per million inhabitants 2011-
2015 in the five geographical regions of the ESC and comparison to the total ESC area and 
the 28 member countries of the European Union (EU28).
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Figure 29. Implantable cardioverter-defibrillator implantations per million inhabitants 2011-































































Figure 30. Implantable cardioverter-defibrillator implantations per million inhabitants 2011-



























Figure 31. Implantable cardioverter-defibrillator implantations per million inhabitants 2011-




























Figure 32. Implantable cardioverter-defibrillator implantations per million inhabitants 2011-




























Figure 33. Implantable cardioverter-defibrillator implantations per million inhabitants 2011-
2015 in the non-European ESC countries. 
* No data available
* * *
*





































































































































































































































































































































































































































































































































































































































































Figure 38. Implantable cardioverter defibrillator implantation centres and rates in the ESC and 
European Union (EU28) member countries in 2015. Bubble size is related to population in the 
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Figure 40. Cardiac resynchronization therapy (CRT) device implanting centres per million 
inhabitants in 2015. The mean number of CRT implantation centres is weighted by population.
Figure 41. Cardiac resynchronization therapy device implantations per million inhabitants 


















































Median number of CRT implantations = 60


















































82 = Ø CRT implantations per million 
inhabitants (weighted by population)
1st quartile ≥ 2 ≤ 17
2nd quartile > 17 ≤ 60
3rd quartile > 60 ≤ 109
4th quartile > 109 ≤ 261
82 = Ø CRT implantations per million 
inhabitants (weighted by population)
1st quartile ≥ 2 ≤ 17
2nd quartile > 17 ≤ 60
3rd quartile > 60 ≤ 109
4th quartile > 109 ≤ 261
Not available
Figure 42. Cardiac resynchronization therapy device implantations in the ESC countries in 
2015.
Figure 43. Cardiac resynchronization therapy pacemaker (CRT-P) implantations per million 



























































































Figure 44. Cardiac resynchronization therapy defibrillator (CRT-D) implantations per million 















































































































Figure 45. Cardiac resynchronization therapy device implantations per million inhabitants 
2011-2015 in the five geographical regions of the ESC and comparison to the total ESC area 
and the 28 member countries of the European Union (EU28).
Northern Europe Western Europe












































































Figure 47. Cardiac resynchronization therapy implantations per million inhabitants 2011-2015 in 

























































Figure 49. Cardiac resynchronization therapy implantations per million inhabitants 2011-2015 in 
Southern Europe.























Figure 50. Cardiac resynchronization therapy implantations per million inhabitants 2011-2015 in 
the non-European ESC countries. *No data available
*
* * **






























































































































































































































































































































































































































































































































































































































































































































Figure 55. Cardiac resynchronization therapy implantation centres and rates in the ESC and 
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Figure 56. Lead extractions per million inhabitans in 2015. The mean number of lead 



































































Mean number of Lead extractions = Ø 12,8
San Marino
Iceland
Figure 57. Catheter ablation centres per million inhabitants in 2015. The mean 

























































































































































































































































Figure 59. Catheter ablations per million inhabitants in 2015. The mean number of 













































Mean number of ablations = Ø 259













































259 = Ø Ablations per million inhabitants 
(weighted by population)
1st quartile ≥ 0 ≤ 79
2nd quartile > 79 ≤ 229
3rd quartile > 229 ≤ 368
4th quartile > 368 ≤ 789
259 = Ø  Ablations per million 
inhabitants (weighted by population)
1st quartile ≥ 0 ≤ 79
2nd quartile > 79 ≤ 229
3rd quartile > 229 ≤ 368
4th quartile > 368 ≤ 789
Not available


















































































































































Figure 61. Change in the number of catheter ablations per million inhabitants from 2014 to 2015.
Figure
Figure 62. Catheter ablation centres and rates in the ESC and European Union (EU28) 
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Figure 63. Catheter ablations per million inhabitants 2011-2015 in the five geographical 
regions of the ESC and comparison to the total ESC area and the 28 member countries of the 
European Union (EU28).
Northern Europe Western Europe























































































































































Figure 68. Catheter ablations per million inhabitants 2011-2015 in the non-European ESC 
















































Median number of ablations = 50









































96 = Ø AF ablations per million inhabitants 
(weighted by population)
1st quartile ≥ 0 ≤ 14
2nd quartile > 14 ≤ 50
3rd quartile > 50 ≤ 117
4th quartile > 117 ≤ 416
Figure 69. Atrial fibrillation (AF) ablations per million inhabitants in 2015. The mean number 
of AF ablations is weighted by population.
96 = Ø  AF Ablations per million 
inhabitants (weighted by population)
1st quartile ≥ 0 ≤ 14
2nd quartile > 14 ≤ 50
3rd quartile > 50 ≤ 117
4th quartile > 117 ≤ 416
Not available
Figure 70. Atrial fibrillation ablations in the ESC countries in 2015.































































































































































Figure 72. Atrial fibrillation ablations per million inhabitants 2011-2015 in the five geographical 
regions of the ESC and comparison to the total ESC area and the 28 member countries of the 
European Union (EU28).
Northern Europe Western Europe
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Figure 77. Atrial fibrillation ablations per million inhabitants 2011-2015 in the non-European ESC 










































































































































Figure 79. Number of centres which performed more than 10 VT or VF ablations per million 
inhabitants in patients with structural heart disease in 2015. The mean number of VT/VF ablation 






























































Mean number of VT/VF-ablations = Ø 16
Slovakia
Ireland








Figure 80. Ablations for VT or VF per million inhabitants in patients with structural heart 
disease in 2015. The mean number of VT/VF-ablations is weighted by population.
16 = Ø VT/VF-ablations per million 
inhabitants (weighted by population)
1st quartile ≥ 0 ≤ 1
2nd quartile > 1 ≤ 11
3rd quartile > 11 ≤ 18
4th quartile > 18≤ 83
16 = Ø  VT/VF-ablations per million 
inhabitants (weighted by population)
1st quartile ≥ 0 ≤ 1
2nd quartile > 1 ≤ 11
3rd quartile > 11 ≤ 18
4th quartile > 18 ≤ 83
Not available



























































Figure 82. Number of centres performing LAA closures per million inhabitants in 2015. The 














































Figure 83. Percutaneous LAA closures per million inhabitants in 2015. The mean number of the 



































Figure 84. Healthcare spending per capita and interventional electrophysiology 
procedures (sum of PM-ICD-CRT-Ablation procedures per million inhabitants). The ISO 
codes of the countries are explained in Table 1.
























No answer = 3 countries
No = 32 countries
Yes = 15 countries
Figure 85. Availability of national institution to coordinate and guide device recalls in the 
ESC countries in 2015.
Table 1 Populations in the five geographical ESC regions in 2011-2015
Region Country ISO code 2011 2012 2013 2014 2015
Northern Europe Denmark DK  5 529 888  5 543 453  5 556 452  5 569 077  5 581 503
Estonia EE  1 282 963  1 274 709  1 266 375  1 257 921  1 265 420
Finland FI  5 259 250  5 262 930  5 266 114  5 268 799  5 476 922
Iceland IS   311 058   313 183   315 281   317 351   331 918
Ireland IE  4 670 976  4 722 028  4 775 982  4 832 765  4 892 305
Latvia LV  2 204 708  2 191 580  2 178 443  2 165 165  1 986 705
Lithuania LT  3 535 547  3 525 761  3 515 858  3 505 738  2 884 433
Norway NO  4 691 849  5 000 000  5 085 582  5 147 792  5 207 689
Sweden SE  9 088 728  9 103 788  9 647 386  9 723 809  9 801 616
United Kingdom GB  62 698 362  63 047 162  63 395 574  63 742 977  64 088 222
Northern Europe Total  99 273 329  99 984 594  101 003 047  101 531 394  101 516 733
Western Europe Austria AT  8 217 280  8 219 743  8 221 646  8 223 062  8 665 550
Belgium BE  10 431 477  10 438 353  10 444 268  10 449 361  11 323 973
France FR  65 102 719  65 630 692  65 951 611  66 259 012  66 553 766
Germany DE  81 471 834  81 305 856  81 147 265  80 996 685  80 854 408
Luxembourg LU   503 302   509 074   514 862   520 672   570 252
Netherlands NL  16 653 734  16 730 632  16 805 037  16 877 351  16 947 904
Switzerland CH  7 639 961  7 925 517  7 996 026  8 061 516  8 121 830
Western Europe Total  190 020 307  190 759 867  191 080 715  191 387 659  193 037 683
Eastern Europe Belarus BY  9 577 552  9 643 566  9 625 888  9 608 058  9 498 364
Bulgaria BG  7 093 635  7 037 935  6 981 642  6 924 716  7 186 893
Czech Republic CZ  10 190 213  10 177 300  10 609 762  10 627 448  10 644 842
Hungary HU  9 976 062  9 958 453  9 939 470  9 919 128  9 897 541
Moldova MD  3 694 121  3 656 843  3 619 925  3 583 288  3 546 847
Poland PL  38 441 588  38 415 284  38 383 809  38 346 279  38 562 189
Romania RO  21 904 551  21 848 504  21 790 479  21 729 871  21 666 350
Russian Federation RU  138 739 892  142 517 670  142 500 482  142 470 272  142 423 773
Slovakia SK  5 477 038  5 483 088  5 488 339  5 492 677  5 415 949
Ukraine UA  45 134 707  45 416 589  44 573 205  44 291 413  44 429 471
Eastern Europe Total  290 229 359  294 155 232  293 513 001  292 993 150  293 272 219
Southern Europe Albania AL  2 994 667  3 002 859  3 011 405  3 020 209  3 029 278
Bosnia & Herzegovina BA  4 622 163  3 879 296  3 875 723  3 871 643  3 867 055
Croatia HR  4 483 804  4 480 043  4 475 611  4 470 534  4 464 844
Greece GR  10 760 136  10 767 827  10 772 967  10 775 557  10 775 643
Italy IT  61 016 804  61 261 254  61 482 297  61 680 122  61 855 120
Kosovo XK  1 825 632  1 836 529  1 847 708  1 859 203  1 870 981
FYR Macedonia MK  2 077 328  2 082 370  2 087 171  2 091 719  2 096 015
Malta MT   408 333   409 836   411 277   412 655   413 965
Montenegro ME   661 807   657 394   653 474   650 036   647 073
Portugal PT  10 760 305  10 781 459  10 799 270  10 813 834  10 825 309
San Marino SM   31 817   32 140   32 448   32 742   33 020
Serbia RS  7 310 555  7 276 604  7 243 007  7 209 764  7 176 794
Slovenia SI  2 000 092  1 996 617  1 992 690  1 988 292  1 983 412
Spain ES  46 754 784  47 042 984  47 370 542  47 737 941  48 146 134
Southern Europe Total  155 708 227  155 507 212  156 055 590  156 614 251  157 184 643
Non-European ESC countries Algeria DZ  34 994 937  37 367 226  38 087 812  38 813 722  39 542 166
Armenia AM  2 967 975  2 970 495  3 064 267  3 060 927  3 056 382
Azerbaijan AZ  9 397 279  9 493 600  9 590 159  9 686 210  9 780 780
Cyprus CY  1 120 489  1 138 071  1 155 403  1 172 458  1 189 197
Egypt EG  82 079 636  83 688 164  85 294 388  86 895 099  88 487 396
Georgia GE  4 585 874  4 570 934  4 942 157  4 935 880  4 931 226
Israel IL  7 473 052  7 590 758  7 707 042  7 821 850  8 049 314
Kazakhstan KZ  17 304 513  17 736 896  17 736 896  17 948 816  18 157 122
Kyrgyzstan KGZ  5 450 776  5 496 737  5 548 042  5 604 212  5 664 939
Lebanon LB  4 143 101  4 140 289  4 131 583  4 136 895  6 184 701
Libya LY  6 597 960  5 613 380  6 002 347  6 244 174  6 411 776
Morocco MA  31 968 361  32 309 239  32 649 130  33 478 299  33 322 699
Syria SY  22 517 750  22 530 746  22 457 336  22 597 531  17 064 854
Tunisia TN  10 629 186  10 732 900  10 835 873  10 937 521  11 037 225
Turkey TR  78 785 548  79 749 461  80 694 485  81 619 392  79 414 269
Non-European ESC countries Total  320 016 437  325 128 896  329 896 920  334 952 986  332 294 046
Total ESC countries 1 055 247 659 1 065 535 801 1 071 549 273 1 077 479 440 1 077 305 324
Table
Table 2 Population, vital statistics and GPD in the 56 ESC countries.
Country Population Population growth rate (%) Life expectancy at birth (years) Death rate per 1000 population GDP (x 1000 billion USD) GDP per capita (USD) Total health expenditure as % of GDP
Albania*   3 029 278 0.30 78.1 5.68  11.59 4 200 5.88
Algeria   39 542 166 1.86 76.6 N/A  175.08 4 345 N/A
Armenia   3 056 382 -0.14 74.4 9.13  10.61 3 547 4.52
Austria   8 665 550 0.58 81.4 9.16  372.61 43 547 11.03
Azerbaijan   9 780 780 0.97 72.2 5.88  63.98 6 794 5.58
Belarus   9 498 364 -0.10 73.2 12.60  62.02 6 583 6.07
Belgium   11 323 973 0.77 80.9 9.83  458.65 40 456 11.19
Bosnia & Herzegovina   3 867 055 -0.12 76.6 9.12  15.57 4 030 9.63
Bulgaria   7 186 893 -0.57 74.4 14.96  47.17 6 582 7.63
Croatia   4 464 844 -0.13 76.6 11.84  48.93 11 551 7.30
Cyprus   1 189 197 1.42 78.5 6.37  19.38 21 531 7.44
Czech Republic   10 644 842 0.16 78.5 10.39  182.46 17 330 7.24
Denmark   5 581 503 0.22 79.3 9.31  291.04 51 424 10.62
Egypt   88 487 396 1.82 73.7 N/A N/A N/A N/A
Estonia   1 265 420 -0.56 76.5 11.35  22.93 17 425 5.72
Finland   5 476 922 0.41 80.8 9.46  230.69 42 159 9.40
France   66 553 766 0.44 81.8 8.49 2 422.65 37 728 11.66
Georgia   4 931 226 -0.09 76.0 13.17  13.75 3 720 9.43
Germany   80 854 408 -0.18 80.6 11.08 3 371.00 41 267 11.30
Greece   10 775 643 0.00 80.4 10.52  192.98 17 657 9.82
Hungary   9 897 541 -0.22 75.7 12.81  118.49 12 021 8.05
Iceland    331 918 1.23 83.0 6.27  16.74 51 068 9.06
Ireland   4 892 305 1.22 80.7 6.36  227.50 48 940 8.92
Israel   8 049 314 1.61 82.3 5.15  298.87 35 702 7.24
Italy   61 855 120 0.28 82.1 10.30 1 819.05 29 847 9.09
Kazakhstan   18 157 122 1.15 70.6 8.51  195.01 11 028 4.26
Kosovo   1 870 981 0.63 71.3 N/A  6.31 N/A N/A
Kyrgyzstan   5 664 939 1.08 70.4 6.10  7.16 1 198 6.67
Latvia   1 986 705 -1.05 74.2 14.28  27.82 13 729 5.72
Lebanon*   6 184 701 5.01 77.4 N/A  54.40 11 945 N/A
Libya*   6 411 776 2.65 76.3 N/A  29.72 4 754 N/A
Lithuania   2 884 433 -1.04 74.7 13.70  41.78 14 318 6.24
Luxembourg    570 252 2.17 82.2 6.76  57.93 103 187 7.10
FYR Macedonia   2 096 015 0.21 76.0 9.30  10.09 4 867 6.44
Malta    413 965 0.32 80.3 7.65  9.19 21 540 8.73
Moldova*   3 546 847 -1.02 70.4 10.70  6.19 1 740 11.80
Montenegro    647 073 -0.46 78.4 9.29  3.99 6 373 6.49
Morocco   33 322 699 1.01 76.7 6.34  103.08 3 077 N/A
Netherlands   16 947 904 0.42 81.2 8.41  750.78 44 333 12.89
Norway   5 207 689 1.16 81.7 8.11  397.59 76 266 9.57
Poland   38 562 189 -0.08 77.4 10.06  481.24 12 662 6.66
Portugal   10 825 309 0.11 79.2 10.22  197.51 18 984 9.71
Romania   21 666 350 -0.29 74.9 11.99  174.92 8 807 5.34
Russian Federation   142 423 773 -0.03 70.5 13.47 1 235.86 8 447 6.55
San Marino    33 020 0.85 83.2 7.34  1.54 49139.01 6.49
Serbia   7 176 794 -0.46 75.3 14.00  36.56 5 102 10.60
Slovakia   5 415 949 0.03 76.9 9.84  86.20 15 893 8.21
Slovenia   1 983 412 -0.25 78.0 9.08  42.74 20 712 9.16
Spain   48 146 134 0.85 81.6 8.38 1 221.39 26 327 8.88
Sweden   9 801 616 0.80 82.0 9.43  483.72 48 966 9.71
Switzerland   8 121 830 0.75 82.5 8.03  676.98 82 178 11.47
Syria*   17 064 854 -5.07 74.7 N/A N/A N/A N/A
Tunisia*   11 037 225 0.91 75.9 N/A  44.27 3 985 N/A
Turkey   79 414 269 1.28 74.6 4.70  722.22 9 290 5.59
Ukraine   44 429 471 -1.15 71.6 14.60  90.14 2 109 7.77
United Kingdom   64 088 222 0.54 80.5 8.99 2 864.90 44 118 9.12
* These 6 countries did not submit data for the EHRA White Book 2016.





(% of population) Public insurance Private insurance Private co-payment
Possibility to subscribe 
to private health 
insurance plans ICD PM Ablation
Albania*
Algeria Yes 30 100 0 0 Yes No Yes No
Armenia No 67 0 100 0 Yes Yes Yes Yes
Austria Yes 2 99 0 0 Yes No No No
Azerbaijan Yes 0 80 10 10 Yes Yes No Yes
Belarus Yes 0 100 N/A N/A Yes No No No
Belgium Yes 1 90 0 10 Yes No No Yes
Bosnia & Herzegovina No 25 75 N/A 25 No Yes Yes N/A
Bulgaria Yes 20 75 1 24 Yes Yes No Yes
Croatia Yes 10 90 5 5 Yes No No No
Cyprus No 15 85 15 0 Yes No No No
Czech Republic Yes 0.1 99.8 0.1 0.1 No No No No
Denmark Yes 0 100 0 0 Yes No No No
Egypt No 35 64 1 35 Yes Yes Yes Yes
Estonia Yes N/A N/A N/A N/A N/A No No No
Finland Yes 0 75.6 3 21.4 Yes No No No
France Yes 0 100 N/A N/A Yes No No No
Georgia Yes N/A N/A N/A N/A Yes Yes Yes Yes
Germany Yes 1 87 13 N/A Yes No No No
Greece Yes 25 90 10 0 Yes N/A N/A N/A
Hungary Yes 2 99 1 0 Yes No No No
Iceland Yes 0 100 0 0 No No No No
Ireland Yes 0 100 46 46 Yes No No No
Israel Yes 0 100 0 0 Yes No No No
Italy Yes 0 100 0 0 Yes No No No
Kazakhstan No N/A N/A N/A N/A Yes No No No
Kosovo No N/A N/A N/A N/A N/A No No No
Kyrgyzstan Yes N/A N/A N/A N/A Yes Yes Yes Yes
Latvia Yes 0 81 19 N/A Yes Yes Yes No
Lebanon*
Libya*
Lithuania Yes 0 98 2 0 Yes No No No
Luxembourg Yes 0 100 N/A N/A Yes No No No
FYR Macedonia No 10 90 10 N/A Yes No No No
Malta Yes 0 N/A N/A N/A Yes No No No
Moldova*
Montenegro Yes 1 99 N/A 1 No No No No
Morocco No 25 80 15 5 Yes Yes Yes Yes
Netherlands Yes 0 0 100 0 Yes No No No
Norway Yes 0 99 0 1 Yes No No No
Poland Yes N/A 90 0 10 Yes No No No
Portugal Yes 0 100 0 0 Yes No No No
Romania Yes N/A 100 0 0 No Yes Yes Yes
Russian Federation Yes N/A 90 7 3 Yes No Yes No
San Marino Yes 0 100 0 0 Yes No No No
Serbia Yes 0 100 0 0 Yes No No No
Slovakia Yes 0 75 25 0 No No No No
Slovenia Yes 1 4 0 96 N/A No No No
Spain Yes 1 79 5 16 Yes No No No
Sweden N/A N/A N/A N/A N/A N/A N/A N/A N/A
Switzerland Yes N/A 0 100 0 Yes No No No
Syria*
Tunisia*
Turkey Yes 1 99 1 N/A Yes No No No
Ukraine No N/A N/A N/A N/A Yes No No No
United Kingdom No 95 95 0 5 Yes No No No
Distribution of insurance modality (%) Co-payment necessary for therapies
* These 6 countries did not submit data for the EHRA White Book 2016.
Table 4 Pacemaker implantation facilities and implantation rates in 2015 in comparison to four previous years












inhabitants To attain mean ESC area level To attain mean EU-28 level 2011 2012 2013 2014 2015
Albania* AL N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A  44 N/A
Algeria DZ No 19  0 2 915  74 20 481 34 883 N/A N/A  65  65  74
Armenia AM No 2  1  117  38 1 583 2 696  133  74  31  42  38
Austria AT Yes 57  7 7 905  912 - -  950  957  967 1 006  912
Azerbaijan AZ No 8  1  395  40 5 066 8 628  15 N/A  14  19  40
Belarus BY No 10  1 3 149  332 4 920 8 379  258  275  292  309  332
Belgium BE Yes 104  9 13 073 1 154 - - N/A 1 228 1 218 1 236 1 154
Bosnia & Herzegovina BA No 6  2  854  221 2 003 3 411  138  234  224  215  221
Bulgaria BG Yes 19  3 3 953  550 - 6 340  385  448  503  538  550
Croatia HR No 17  4 2 855  639 - 3 939  565  561  540  582  639
Cyprus CY No 5  4  280  235  616 1 049  223  211  216  213  235
Czech Republic CZ Yes 37  3 8 969  843 - 9 391  881  899  887  889  843
Denmark DK Yes 15  3 4 818  863 - 4 924  795  841  850  866  863
Egypt EG No 33  0 3 552  40 45 833 78 061 N/A  30  33  38  40
Estonia EE No 5  4 1 085  857 - 1 116  766  748  912  838  857
Finland FI No 20  4 5 821 1 063 - -  923  990 1 020 1 051 1 063
France FR No 453  7 64 176  964 - -  969  958  910 1 011  964
Georgia GE No 15  3  817  166 2 554 4 350  84  102  125  123  166
Germany DE Yes 1135  14 106 700 1 320 - - 1 313 1 311 1 152 1 152 1 320
Greece GR Yes 56  5 8 800  817 - 9 506  701  691  724  742  817
Hungary HU Yes 18  2 6 432  650 - 8 731  584  607  618  645  650
Iceland IS No 2  6  308  928 - - 1 006  967  996  939  928
Ireland IE Yes 17  3 2 277  465 2 534 4 316  507  451  479 N/A  465
Israel IL No 20  2 4 250  528 - 7 101  500  558  515  537  528
Italy IT Yes 435  7 65 234 1 055 - - 1 034 1 001 1 012 1 029 1 055
Kazakhstan KZ No 25  1 1 801  99 9 405 16 018 N/A  69  84  131  99
Kosovo XK No 3  2  122  65  969 1 651 N/A N/A N/A  68  65
Kyrgyzstan KGZ N/A 2  0  126  22 2 934 4 997 N/A N/A N/A  22  22
Latvia LV Yes 3  2 1 400  705 - 1 753  550  548  591  571  705
Lebanon* LB N/A N/A N/A N/A N/A N/A N/A N/A N/A  218  218 N/A
Libya* LY N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A
Lithuania LT No 5  2 2 583  895 - -  714  756  772  789  895
Luxembourg LU No 6  11  393  689 -  503  336  621  365  670  689
FYR Macedonia MK No 3  1  470  224 1 086 1 849  174  166  154  170  224
Malta MT No 1  2  400  966 - -  740  644  552  887  966
Moldova* MD N/A N/A N/A N/A N/A N/A N/A N/A N/A  79 N/A N/A
Montenegro ME No 1  2  247  382  335  571  264  218  312  280  382
Morocco MA Yes 11  0 1 801  54 17 260 29 396  39  38  34  44  54
Netherlands NL Yes 85  5 10 000  590 - 14 951  585  560  605  600  590
Norway NO Yes 23  4 4 121  791 - 4 594  675  691  680  755  791
Poland PL No 145  4 30 494  791 - 34 018  710  716  716  742  791
Portugal PT Yes 40  4 8 769  810 - 9 550  595  825  814  817  810
Romania RO No 24  1 3 918  181 11 222 19 113  139  144  110  196  181
Russian Federation RU Yes 140  1 34 492  242 73 770 125 642  216  212  244  266  242
San Marino SM Yes 1  30  11  333  17  29  503  809  431 N/A  333
Serbia RS Yes 17  2 3 724  519 - 6 331  448  431  546  507  519
Slovakia SK Yes 14  3 3 664  677 - 4 778  617  567  630  606  677
Slovenia SI Yes 9  5 1 235  623 - 1 750  647  668  646  736  623
Spain ES Yes 230  5 33 373  693 - 42 473  734  738  749  761  693
Sweden* SE N/A 44  4 N/A N/A N/A N/A N/A 1 041  995  969 N/A
Switzerland CH Yes 71  9 6 401  788 - 7 165  791  753  763  812  788
Syria* SY N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A
Tunisia* TN N/A N/A N/A N/A N/A N/A N/A  155  233 N/A  201 N/A
Turkey TR No N/A N/A 9 200  116 41 134 70 057 N/A N/A N/A  89  116
Ukraine UA No 38  1 4 851  109 23 013 39 194  112  121  148  119  109
United Kingdom GB Yes 211  3 46 110  719 - 56 537  610  615  702  708  719
Total ESC countries 3 660 3.85 528 441  518  649  648  632  660  680
* These 7 countries did not submit any data on PM implantations for the EHRA White Book 2016.
Number of PM implanting 
centres 2015 PM implantations 2015 Development potential - target number of PM implantations
Table 5 Specialty of physicians performing device implantations and lead extractions
Country ISO code Cardiologists Surgeons Other Cardiologists Surgeons Other Cardiologists Surgeons Other Cardiologists Surgeons Other Cardiologists Surgeons
Albania* AL N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A
Algeria DZ 99 1 0 100 0 0 100 0 0 100 0 0 97 3
Armenia AM 100 0 0 100 0 0 100 0 0 100 0 0 0 0
Austria AT 50 50 0 10 90 0 50 50 0 80 20 0 10 90
Azerbaijan AZ 90 10 0 100 0 0 100 0 0 100 0 0 100 0
Belarus BY 0 100 0 0 100 0 0 100 0 0 100 0 0 100
Belgium BE N/A N/A 0 N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A
Bosnia & Herzegovina BA 85 15 0 85 15 0 100 0 0 100 0 0 N/A N/A
Bulgaria BG 90 10 0 100 0 0 100 0 0 100 0 0 100 0
Croatia HR 90 10 0 95 5 0 100 0 0 100 0 0 100 0
Cyprus CY 100 0 0 100 0 0 100 0 0 100 0 0 100 0
Czech Republic CZ 95 5 0 95 5 0 95 5 0 100 0 0 80 20
Denmark DK 100 0 0 100 0 0 100 0 0 100 0 0 85 15
Egypt EG 100 0 0 90 0 10 70 0 30 0 0 0 90 0
Estonia EE 100 0 0 100 0 0 100 0 0 100 0 0 N/A N/A
Finland FI 95 5 0 95 5 0 100 0 0 100 0 0 100 0
France FR 90 10 0 95 5 0 100 0 0 100 0 0 90 10
Georgia GE 90 10 0 100 0 0 100 0 0 100 0 0 N/A N/A
Germany DE 60 28 12 67 21 12 68 20 12 92 2 6 17 83
Greece GR 97 3 0 98 2 0 98 2 0 100 0 0 90 10
Hungary HU 95 5 0 97 3 0 97 3 0 100 0 0 95 5
Iceland IS 50 50 0 50 50 0 100 0 0 100 0 0 100 0
Ireland IE 100 0 0 100 0 0 100 0 0 100 0 0 50 50
Israel IL 98 2 0 100 0 0 100 0 0 100 0 0 99 1
Italy IT 100 0 0 100 0 0 100 0 0 100 0 0 100 0
Kazakhstan KZ N/A N/A 0 N/A N/A N/A N/A N/A N/A 100 0 0 100 0
Kosovo XK 100 0 0 100 N/A N/A 80 0 20 100 0 0 100 0
Kyrgyzstan KGZ N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A
Latvia LV 70 30 0 70 30 0 70 30 0 70 30 0 0 100
Lebanon* LB N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A
Libya* LY N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A
Lithuania LT 99 1 0 100 0 0 100 0 0 100 0 0 95 5
Luxembourg LU 85 15 0 98 2 0 90 10 0 100 0 0 0 100
FYR Macedonia MK 100 0 0 100 0 0 100 0 0 100 0 0 50 50
Malta MT 100 0 0 100 0 0 100 0 0 100 0 0 100 0
Moldova* MD N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A
Montenegro ME 70 30 0 50 50 0 100 0 0 50 50 0 50 50
Morocco MA 99 1 0 N/A N/A N/A 99 1 0 0 0 0 99 1
Netherlands NL 95 2 3 95 3 2 97 3 0 85 5 10 90 10
Norway NO 99.7 0.3 0 100 0 0 100 0 0 100 0 0 100 0
Poland PL 99 1 0 99 1 0 100 0 0 100 0 0 99 1
Portugal PT 99 1 0 100 0 0 100 0 0 100 0 0 N/A N/A
Romania RO 99 1 0 100 0 0 100 0 0 100 0 0 100 0
Russian Federation RU 80 18 2 70 30 0 40 60 0 N/A N/A N/A N/A N/A
San Marino SM 100 0 0 100 0 0 100 0 0 100 0 0 0 0
Serbia RS 98 2 0 100 0 0 100 0 0 100 0 0 100 0
Slovakia SK 98 2 0 98 2 0 100 0 0 100 0 0 95 5
Slovenia SI 20 80 0 N/A N/A N/A 100 0 0 50 50 0 0 100
Spain ES 72 24 4 92 8 0 98 2 0 100 0 0 30 70
Sweden SE 64 18 18 81 14 5 N/A N/A N/A N/A N/A N/A N/A N/A
Switzerland CH 95 5 0 95 5 0 100 0 0 100 0 0 80 20
Syria* SY N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A
Tunisia* TN N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A
Turkey TR 95 5 0 97 3 0 99 1 0 100 0 0 75 25
Ukraine UA 10.3 89.7 0 14.3 85.7 0 20 80 0 50 50 0 0 100
United Kingdom GB 100 0 0 100 0 0 100 0 0 100 0 0 100 0
* These 6 countries did not submit data for the EHRA White Book 2016.
Specialist performing PM 
implantations (%)
Specialist performing ICD 
implantations (%)
Specialist performing CRT 
implantations (%)
Specialist performing loop recorder 
implantations (%)



























































Specialist performing lead 
extractions (%)
Table 6 Changes in the number of pacemaker (PM) implantation centres in year 2014 vs. 2015
Country ISO code Absolute number Per mil inhabitants Absolute number Per mil inhabitants Change %
Albania* AL 4 1.32 N/A N/A N/A
Algeria DZ 19 0.49 19 0.48 -1.8%
Armenia AM 3 0.98 2 0.65 -33.2%
Austria AT 57 6.93 57 6.58 -5.1%
Azerbaijan AZ 10 1.03 8 0.82 -20.8%
Belarus BY 10 1.04 10 1.05 1.2%
Belgium BE 104 9.95 104 9.18 -7.7%
Bosnia & BA 5 1.29 6 1.55 20.1%
Bulgaria BG 17 2.45 19 2.64 7.7%
Croatia HR 18 4.03 17 3.81 -5.4%
Cyprus CY 5 4.26 5 4.20 -1.4%
Czech Republic CZ 37 3.48 37 3.48 -0.2%
Denmark DK 11 1.98 15 2.69 36.1%
Egypt EG 33 0.38 33 0.37 -1.8%
Estonia EE 5 3.97 5 3.95 -0.6%
Finland FI 20 3.80 20 3.65 -3.8%
France FR 451 6.81 453 6.81 0.0%
Georgia GE 9 1.82 15 3.04 66.8%
Germany DE 980 12.10 1135 14.04 16.0%
Greece GR 56 5.20 56 5.20 0.0%
Hungary HU 18 1.81 18 1.82 0.2%
Iceland IS 2 6.30 2 6.03 -4.4%
Ireland IE 17 3.52 17 3.47 -1.2%
Israel IL 20 2.56 20 2.48 -2.8%
Italy IT 433 7.02 435 7.03 0.2%
Kazakhstan KZ 22 1.23 25 1.38 12.3%
Kosovo XK 2 1.08 3 1.60 49.1%
Kyrgyzstan KGZ 2 0.36 2 0.35 -1.1%
Latvia LV 3 1.39 3 1.51 9.0%
Lebanon* LB 15 3.63 N/A N/A N/A
Libya* LY N/A N/A N/A N/A N/A
Lithuania LT 4 1.14 5 1.73 51.9%
Luxembourg LU 5 9.60 6 10.52 9.6%
FYR Macedonia MK 3 1.43 3 1.43 -0.2%
Malta MT 1 2.42 1 2.42 -0.3%
Moldova* MD N/A N/A N/A N/A N/A
Montenegro ME 1 1.54 1 1.55 0.5%
Morocco MA 11 0.33 11 0.33 0.5%
Netherlands NL 83 4.92 85 5.02 2.0%
Norway NO 23 4.47 23 4.42 -1.2%
Poland PL 150 3.91 145 3.76 -3.9%
Portugal PT 39 3.61 40 3.70 2.5%
Romania RO 24 1.10 24 1.11 0.3%
Russian Federation RU 140 0.98 140 0.98 0.0%
San Marino SM N/A N/A 1 30.28 N/A
Serbia RS 17 2.36 17 2.37 0.5%
Slovakia SK 13 2.37 14 2.58 9.2%
Slovenia SI 7 3.52 9 4.54 28.9%
Spain ES 230 4.82 230 4.78 -0.8%
Sweden SE 45 4.63 44 4.49 -3.0%
Switzerland CH 76 9.43 71 8.74 -7.3%
Syria* SY N/A N/A N/A N/A N/A
Tunisia* TN 20 1.83 N/A N/A N/A
Turkey TR N/A N/A N/A N/A N/A
Ukraine UA 36 0.81 38 0.86 5.2%
United Kingdom GB 207 3.25 211 3.29 1.4%
Total ESC countries 3523 3.69 3660 3.85 4.4%
* These 6 countries did not submit data for the EHRA White Book 2016.
Number of PM implanting centres 2014 Number of PM implanting centres 2015
Table 7 Changes in pacemaker (PM) implantations in year 2014 vs. 2015
Country ISO code Absolute number Per mil inhabitants Absolute number Per mil inhabitants Change %
Albania* AL  134  44 N/A N/A N/A
Algeria DZ 2 508  65 2 915  74 14.1%
Armenia AM  129  42  117  38 -9.2%
Austria AT 8 272 1 006 7 905  912 -9.3%
Azerbaijan AZ  184  19  395  40 112.6%
Belarus BY 2 970  309 3 149  332 7.3%
Belgium BE 12 912 1 236 13 073 1 154 -6.6%
Bosnia & Herzegovina BA  831  215  854  221 2.9%
Bulgaria BG 3 726  538 3 953  550 2.2%
Croatia HR 2 601  582 2 855  639 9.9%
Cyprus CY  250  213  280  235 10.4%
Czech Republic CZ 9 447  889 8 969  843 -5.2%
Denmark DK 4 823  866 4 818  863 -0.3%
Egypt EG 3 320  38 3 552  40 5.1%
Estonia EE 1 054  838 1 085  857 2.3%
Finland FI 5 536 1 051 5 821 1 063 1.2%
France FR 67 000 1 011 64 176  964 -4.6%
Georgia GE  608  123  817  166 34.5%
Germany DE 93 315 1 152 106 700 1 320 14.5%
Greece GR 8 000  742 8 800  817 10.0%
Hungary HU 6 393  645 6 432  650 0.8%
Iceland IS  298  939  308  928 -1.2%
Ireland IE N/A N/A 2 277  465 N/A
Israel IL 4 200  537 4 250  528 -1.7%
Italy IT 63 442 1 029 65 234 1 055 2.5%
Kazakhstan KZ 2 355  131 1 801  99 -24.4%
Kosovo XK  127  68  122  65 -4.5%
Kyrgyzstan KGZ  126  22  126  22 -1.1%
Latvia LV 1 236  571 1 400  705 23.4%
Lebanon* LB  900  218 N/A N/A N/A
Libya* LY N/A N/A N/A N/A N/A
Lithuania LT 2 767  789 2 583  895 13.5%
Luxembourg LU  349  670  393  689 2.8%
FYR Macedonia MK  356  170  470  224 31.8%
Malta MT  366  887  400  966 8.9%
Moldova* MD N/A N/A N/A N/A N/A
Montenegro ME  182  280  247  382 36.3%
Morocco MA 1 465  44 1 801  54 23.5%
Netherlands NL 10 132  600 10 000  590 -1.7%
Norway NO 3 887  755 4 121  791 4.8%
Poland PL 28 470  742 30 494  791 6.5%
Portugal PT 8 830  817 8 769  810 -0.8%
Romania RO 4 258  196 3 918  181 -7.7%
Russian Federation RU 37 832  266 34 492  242 -8.8%
San Marino SM N/A N/A  11  333 N/A
Serbia RS 3 657  507 3 724  519 2.3%
Slovakia SK 3 326  606 3 664  677 11.7%
Slovenia SI 1 464  736 1 235  623 -15.4%
Spain ES 36 322  761 33 373  693 -8.9%
Sweden SE 9 421  969 N/A N/A N/A
Switzerland CH 6 543  812 6 401  788 -2.9%
Syria* SY N/A N/A N/A N/A N/A
Tunisia* TN 2 200  201 N/A N/A N/A
Turkey TR 7 300  89 9 200  116 29.5%
Ukraine UA 5 258  119 4 851  109 -8.0%
United Kingdom GB 45 131  708 46 110  719 1.6%
Total ESC countries 526213 508 528441  518 2.1%
* These 6 countries did not submit data for the EHRA White Book 2016.
Number of PM implantations 2014 Number of PM implantations 2015
ICD implantations per mil inhabitants
Country ISO code National Registry for ICD implants Absolute number Per mil inhabitants Absolute number Per mil inhabitants To attain mean ESC area level To attain mean EU-28 level 2011 2012 2013 2014 2015
Albania* AL N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A 1 N/A
Algeria DZ No 9 0.23  91 2 4 030 6 992 N/A N/A 1 2 2
Armenia AM No 3 0.98  21 7  311  540 12 N/A 9 8 7
Austria AT Yes 21 2.42 1 393 161 - 1 532 220 145 158 166 161
Azerbaijan AZ No 7 0.72  21 2  997 1 729 2 N/A 1 2 2
Belarus BY No 10 1.05  133 14  968 1 680 14 12 16 18 14
Belgium BE Yes 23 2.03 1 531 135 - 2 002 197 210 163 154 135
Bosnia & Herzegovina BA No 6 1.55  87 22  394  684 13 14 17 14 22
Bulgaria BG Yes 10 1.39  51 7  732 1 271 8 7 5 7 7
Croatia HR No 11 2.46  388 87  455  789 19 26 35 39 87
Cyprus CY No 4 3.36  75 63  121  210 58 46 52 62 63
Czech Republic CZ Yes 18 1.69 2 039 192 - - 270 277 301 201 192
Denmark DK Yes 6 1.07 1 208 216 - - 198 218 231 217 216
Egypt EG No 17 0.19  253 3 9 018 15 647 N/A 2 2 3 3
Estonia EE No 2 1.58  91 72  129  224 45 79 82 76 72
Finland FI No 18 3.29 1 198 219 - - 134 166 194 220 219
France FR No 161 2.42 7 825 118 - 11 768 102 106 N/A 207 118
Georgia GE No 12 2.43  140 28  503  872 5 12 12 21 28
Germany DE No 745 9.21 28 914 358 - - 326 326 336 295 358
Greece GR Yes 24 2.23 1 188 110 - 1 905 83 87 97 100 110
Hungary HU Yes 13 1.31  986 100 1 009 1 750 80 85 95 96 100
Iceland IS No 1 3.01  59 178 - - 113 134 171 186 178
Ireland IE Yes 17 3.47  740 151 -  865 140 144 153 N/A 151
Israel IL Yes 20 2.48 1 300 162 - 1 423 156 137 166 215 162
Italy IT Yes 396 6.40 14 709 238 - - 196 196 204 223 238
Kazakhstan KZ No 19 1.05  527 29 1 850 3 211 N/A 7 12 22 29
Kosovo XK No 1 0.53  12 6  191  331 N/A N/A N/A 2 6
Kyrgyzstan KGZ N/A 2 0.35 N/A N/A N/A N/A N/A N/A N/A N/A N/A
Latvia LV Yes 3 1.51  90 45  202  351 29 32 40 35 45
Lebanon* LB N/A N/A N/A N/A N/A N/A N/A N/A N/A 73 73 N/A
Libya* LY N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A
Lithuania LT No 3 1.04  123 43  294  510 33 42 35 38 43
Luxembourg LU Yes 1 1.75  65 114 -  101 99 149 138 119 114
FYR Macedonia MK No 3 1.43  29 14  214  371 13 7 6 5 14
Malta MT No 1 2.42  35 85  42  73 71 132 163 87 85
Moldova* MD N/A N/A N/A N/A N/A N/A N/A N/A N/A 0 N/A N/A
Montenegro ME No 1 1.55  53 82  66  114 47 44 58 63 82
Morocco MA N/A 6 0.18  57 2 3 396 5 892 1 1 1 1 2
Netherlands NL Yes 29 1.71 3 500 207 - - 155 160 244 212 207
Norway NO Yes 11 2.11 1 214 233 - - 184 199 214 220 233
Poland PL No 122 3.16 8 526 221 - - 157 182 234 219 221
Portugal PT Yes 29 2.68 1 224 113 - 1 914 95 92 N/A N/A 113
Romania RO No 16 0.74  300 14 2 208 3 831 8 8 9 15 14
Russian Federation RU Yes 48 0.34 1 553 11 14 515 25 184 10 11 13 12 11
San Marino SM Yes 1 30.28  8 242 - - 597 404 616 N/A 242
Serbia RS Yes 11 1.53  437 61  731 1 269 44 38 62 63 61
Slovakia SK Yes 4 0.74  665 123 -  958 100 105 108 120 123
Slovenia SI Yes 3 1.51  228 115 -  351 72 61 71 88 115
Spain ES Yes 180 3.74 5 348 111 - 8 513 74 73 82 81 111
Sweden SE N/A 30 3.06 N/A N/A N/A N/A N/A 193 198 216 N/A
Switzerland CH Yes 49 6.03 1 830 225 - - 142 195 201 166 225
Syria* SY N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A
Tunisia* TN N/A N/A N/A N/A N/A N/A N/A 8 9 N/A 13 N/A
Turkey* TR No N/A N/A 6 381 80 8 093 14 042 N/A N/A N/A 77 80
Ukraine UA No 14 0.32  52 1 4 528 7 856 1 1 2 1 1
United Kingdom GB Yes 125 1.95 6 701 105 - 11 332 86 91 92 102 105
Total ESC countries 2 266 2.38 103 399 102  102  106  108  118  113
* These 6 countries did not submit any data on ICD implantations for the EHRA White Book 2016.
Number of ICD implanting centres 2015 ICD implantations 2015 Development potential - target number of ICD implantations
Table 9 Changes in the number of ICD implantation centres in year 2014 vs. 2015
Country ISO code Absolute number Per mil inhabitants Absolute number Per mil inhabitants Change %
Albania* AL 2 0.66 N/A N/A N/A
Algeria DZ 8 0.21 9 0.23 10.4%
Armenia AM 3 0.98 3 0.98 0.1%
Austria AT 21 2.55 21 2.42 -5.1%
Azerbaijan AZ 7 0.72 7 0.72 -1.0%
Belarus BY 10 1.04 10 1.05 1.2%
Belgium BE 23 2.20 23 2.03 -7.7%
Bosnia & BA 5 1.29 6 1.55 20.1%
Bulgaria BG 9 1.30 10 1.39 7.1%
Croatia HR 12 2.68 11 2.46 -8.2%
Cyprus CY 4 3.41 4 3.36 -1.4%
Czech Republic CZ 17 1.60 18 1.69 5.7%
Denmark DK 6 1.08 6 1.07 -0.2%
Egypt EG 16 0.18 17 0.19 4.3%
Estonia EE 2 1.59 2 1.58 -0.6%
Finland FI 19 3.61 18 3.29 -8.9%
France FR 162 2.44 161 2.42 -1.1%
Georgia GE 8 1.62 12 2.43 50.1%
Germany DE 670 8.27 745 9.21 11.4%
Greece GR 24 2.23 24 2.23 0.0%
Hungary HU 13 1.31 13 1.31 0.2%
Iceland IS 1 3.15 1 3.01 -4.4%
Ireland IE 17 3.52 17 3.47 -1.2%
Israel IL 20 2.56 20 2.48 -2.8%
Italy IT 397 6.44 396 6.40 -0.5%
Kazakhstan KZ 15 0.84 19 1.05 25.2%
Kosovo XK 1 0.54 1 0.53 -0.6%
Kyrgyzstan KGZ 0 0.00 2 0.35 N/A
Latvia LV 3 1.39 3 1.51 9.0%
Lebanon* LB 15 3.63 N/A N/A N/A
Libya* LY N/A N/A N/A N/A N/A
Lithuania LT 3 0.86 3 1.04 21.5%
Luxembourg LU 1 1.92 1 1.75 -8.7%
FYR Macedonia MK 2 0.96 3 1.43 49.7%
Malta MT 1 2.42 1 2.42 -0.3%
Moldova* MD N/A N/A N/A N/A N/A
Montenegro ME 1 1.54 1 1.55 0.5%
Morocco MA 7 0.21 6 0.18 -13.9%
Netherlands NL 28 1.66 29 1.71 3.1%
Norway NO 11 2.14 11 2.11 -1.2%
Poland PL 120 3.13 122 3.16 1.1%
Portugal PT 31 2.87 29 2.68 -6.6%
Romania RO 15 0.69 16 0.74 7.0%
Russian Federation RU 55 0.39 48 0.34 -12.7%
San Marino SM N/A N/A 1 30.28 N/A
Serbia RS 10 1.39 11 1.53 10.5%
Slovakia SK 4 0.73 4 0.74 1.4%
Slovenia SI 2 1.01 3 1.51 50.4%
Spain ES 112 2.35 180 3.74 59.4%
Sweden SE 35 3.60 30 3.06 -15.0%
Switzerland CH 52 6.45 49 6.03 -6.5%
Syria* SY N/A N/A N/A N/A N/A
Tunisia* TN 8 0.73 N/A N/A N/A
Turkey TR N/A N/A N/A N/A N/A
Ukraine UA 8 0.18 14 0.32 74.5%
United Kingdom GB 126 1.98 125 1.95 -1.3%
Total ESC countries 2 142 2.24 2 266 2.38 6.3%
* These 6 countries did not submit data for the EHRA White Book 2016.
Number of ICD implanting centres 2014 Number of ICD implanting centres 2015
Table 10 Changes in the number of ICD implantations in year 2015 vs. 2014
Country ISO code Absolute number Per mil inhabitants Absolute number Per mil inhabitants Change %
Albania* AL  4 1.32 N/A N/A N/A
Algeria DZ  60 1.55  91 2.30 48.9%
Armenia AM  25 8.17  21 6.87 -15.9%
Austria AT 1 362 165.63 1 393 160.75 -2.9%
Azerbaijan AZ  20 2.06  21 2.15 4.0%
Belarus BY  172 17.90  133 14.00 -21.8%
Belgium BE 1 611 154.17 1 531 135.20 -12.3%
Bosnia & Herzegovina BA  55 14.21  87 22.50 58.4%
Bulgaria BG  47 6.79  51 7.10 4.6%
Croatia HR  173 38.70  388 86.90 124.6%
Cyprus CY  73 62.26  75 63.07 1.3%
Czech Republic CZ 2 138 201.18 2 039 191.55 -4.8%
Denmark DK 1 208 216.91 1 208 216.43 -0.2%
Egypt EG  236 2.72  253 2.86 5.3%
Estonia EE  96 76.32  91 71.91 -5.8%
Finland FI 1 161 220.35 1 198 218.74 -0.7%
France FR 13 700 206.76 7 825 117.57 -43.1%
Georgia GE  104 21.07  140 28.39 34.7%
Germany DE 23 898 295.05 28 914 357.61 21.2%
Greece GR 1 080 100.23 1 188 110.25 10.0%
Hungary HU  956 96.38  986 99.62 3.4%
Iceland IS  59 185.91  59 177.75 -4.4%
Ireland IE N/A N/A  740 151.26 N/A
Israel IL 1 685 215.42 1 300 161.50 -25.0%
Italy IT 13 729 222.58 14 709 237.80 6.8%
Kazakhstan KZ  402 22.40  527 29.02 29.6%
Kosovo XK  3 1.61  12 6.41 297.5%
Kyrgyzstan* KGZ  0 0.00 N/A N/A N/A
Latvia LV  75 34.64  90 45.30 30.8%
Lebanon* LB  300 72.52 N/A N/A N/A
Libya* LY N/A N/A N/A N/A N/A
Lithuania LT  134 38.22  123 42.64 11.6%
Luxembourg LU  62 119.08  65 113.98 -4.3%
FYR Macedonia MK  11 5.26  29 13.84 163.1%
Malta MT  36 87.24  35 84.55 -3.1%
Moldova* MD N/A N/A N/A N/A N/A
Montenegro ME  41 63.07  53 81.91 29.9%
Morocco MA  27 0.81  57 1.71 112.1%
Netherlands NL 3 577 211.94 3 500 206.52 -2.6%
Norway NO 1 134 220.29 1 214 233.12 5.8%
Poland PL 8 399 219.03 8 526 221.10 0.9%
Portugal PT N/A N/A 1 224 113.07 N/A
Romania RO  332 15.28  300 13.85 -9.4%
Russian Federation RU 1 769 12.42 1 553 10.90 -12.2%
San Marino SM N/A N/A  8 242.28 N/A
Serbia RS  457 63.39  437 60.89 -3.9%
Slovakia SK  658 119.80  665 122.79 2.5%
Slovenia SI  174 87.51  228 114.95 31.4%
Spain ES 3 869 81.05 5 348 111.08 37.1%
Sweden* SE 2 097 215.66 N/A N/A N/A
Switzerland CH 1 341 166.35 1 830 225.32 35.5%
Syria* SY N/A N/A N/A N/A N/A
Tunisia* TN  140 12.80 N/A N/A N/A
Turkey TR 6 300 77.19 6 381 80.35 4.1%
Ukraine UA  57 1.29  52 1.17 -9.1%
United Kingdom GB 6 474 101.56 6 701 104.56 2.9%
Total ESC countries 101 521 99 103 399 102 2.1%
* These 8 countries did not submit data for ICD implantations for the EHRA White Book 2016.
Number of ICD implants 2014 Number of ICD implants 2015
Table 11 Cardiac resynchronisation therapy device (CRT-P and CRT-D) implantation facilities and rates in the ESC countries in 2015 and comparison to four previous years
CRT implantations per mil inhabitants






Absolute number Absolute number Per mil inhabitants To attain mean ESC area level To attain mean EU-28 level 2011 2012 2013 2014 2015
Albania* AL N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A 1 N/A
Algeria DZ 8 0.20  53  55  108  3 3 250 5 810 N/A N/A 2 1 3
Armenia AM 2 0.65  1  9  10  3  251  449 3 6 3 1 3
Austria AT 18 2.08  470  894 1 364  157 - - 117 107 143 150 157
Azerbaijan AZ 2 0.20  0  24  24  2  804 1 437 2 N/A 2 2 2
Belarus BY 6 0.63 N/A N/A  100  11  781 1 396 5 4 6 5 11
Belgium BE 40 3.53  528  957 1 485  131 - 1 664 58 82 117 127 131
Bosnia & Herzegovina BA 2 0.52  11  6  17  4  318  568 6 5 6 6 4
Bulgaria BG 9 1.25  253  43  296  41  591 1 056 12 28 37 44 41
Croatia HR 8 1.79  125  136  261  58  367  656 12 13 18 28 58
Cyprus CY 4 3.36 N/A N/A  30  25  98  175 21 25 22 25 25
Czech Republic CZ 18 1.69  465 1 487 1 952  183 - - 143 127 162 176 183
Denmark DK 5 0.90  441  544  985  176 - - 158 170 180 173 176
Egypt EG 17 0.19  429  116  545  6 7 274 13 001 N/A 4 5 6 6
Estonia EE 2 1.58  49  24  73  58  104  186 58 53 55 41 58
Finland FI 15 2.74  184  343  527  96 -  805 62 72 83 100 96
France FR 174 2.61 3 888 6 544 10 432  157 - - 123 131 N/A 144 157
Georgia GE 10 2.03  10  52  62  13  405  725 3 7 8 11 13
Germany DE 250 3.09 3 305 17 834 21 139  261 - - 202 221 109 128 261
Greece GR 16 1.48  88  550  638  59  886 1 583 37 45 46 54 59
Hungary HU 14 1.41  496  595 1 091  110 - 1 454 81 89 99 95 110
Iceland IS 1 3.01  13  8  21  63  27  49 48 32 44 82 63
Ireland IE 17 3.47  88  231  319  65  402  719 57 61 79 N/A 65
Israel IL 20 2.48  115 1 337 1 452  180 - - 97 118 158 170 180
Italy IT 380 6.14 2 153 10 662 12 815  207 - - 203 194 198 200 207
Kazakhstan KZ 18 0.99  0  314  314  17 1 493 2 668 N/A 9 12 15 17
Kosovo XK 1 0.53 N/A  4 4  2  154  275 N/A N/A N/A 0 2
Kyrgyzstan* KGZ N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A 0 N/A
Latvia LV 2 1.01  22  85  107  54  163  292 24 35 29 48 54
Lebanon* LB N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A 24 39 N/A
Libya* LY N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A
Lithuania LT 3 1.04  150  45  195  68  237  424 31 39 47 55 68
Luxembourg LU 1 1.75  8  26  34  60  47  84 40 59 43 65 60
FYR Macedonia MK 3 1.43  26  12  38  18  172  308 13 5 8 13 18
Malta MT 1 2.42  10  31  41  99 -  61 56 83 39 116 99
Moldova* MD N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A 0 N/A N/A
Montenegro ME 1 1.55  14  5  19  29  53  95 21 29 15 34 29
Morocco MA 6 0.18  42  42  84  3 2 739 4 896 N/A 2 2 2 3
Netherlands NL 29 1.71  400 1 600 2 000  118 - 2 490 130 124 123 114 118
Norway NO 9 1.73  214  348  562  108 -  765 88 77 84 100 108
Poland PL N/A N/A  645 3 319 3 964  103 - 5 666 66 73 78 97 103
Portugal PT 26 2.40  210  562  772  71  890 1 591 41 52 N/A 64 71
Romania RO 12 0.55  156  120  276  13 1 781 3 183 10 7 9 13 13
Russian Federation RU 37 0.26  340  666 1 006  7 11 708 20 926 6 6 7 6 7
San Marino SM 1 30.28  0  2  2  61  3  5 94 62 0 N/A 61
Serbia RS 6 0.84  234  79  313  44  590 1 054 40 42 45 45 44
Slovakia SK 4 0.74  209  379  588  109 -  796 60 61 82 96 109
Slovenia SI 2 1.01  47  117  164  83 -  291 45 70 66 75 83
Spain ES 130 2.70  910 1 818 2 728  57 3 958 7 074 56 53 54 62 57
Sweden SE 25 2.55  440  594 1 034  105 - 1 440 N/A 49 100 88 105
Switzerland CH 36 4.43  395  738 1 133  140 - 1 193 74 66 60 72 140
Syria* SY N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A
Tunisia* TN N/A N/A N/A N/A N/A N/A N/A N/A 8 23 N/A 16 N/A
Turkey TR N/A N/A  230 2 580 2 810  35 6 528 11 668 N/A N/A N/A 30 35
Ukraine UA 10 0.23  60  13  73  2 3 652 6 528 1 1 2 2 2
United Kingdom GB 126 1.97 4 160 6 038 10 198  159 - - 105 110 122 149 159
Total ESC countries 1 527 1.68 22 087 61 988 84 205 82 80 83 79 96 102
Number of CRT implanting centres 2015 CRT implantations 2015 Total CRT implantations 2015 Development potential - target number of CRT implantations
* These 7 countries did not submit any data on CRT implantations for the EHRA White Book 2016.
Table 12 Changes in the number of CRT implanting centres in year 2015 vs. 2014
Country ISO code Absolute number Per mil inhabitants Absolute number Per mil inhabitants Change %
Albania* AL 1 0.33 N/A N/A N/A
Algeria DZ 8 0.21 8 0.20 -1.8%
Armenia AM 3 0.98 2 0.65 -33.2%
Austria AT 18 2.19 18 2.08 -5.1%
Azerbaijan AZ 3 0.31 2 0.20 -34.0%
Belarus BY 6 0.62 6 0.63 1.2%
Belgium BE 40 3.83 40 3.53 -7.7%
Bosnia & BA 2 0.52 2 0.52 0.1%
Bulgaria BG 7 1.01 9 1.25 23.9%
Croatia HR 11 2.46 8 1.79 -27.2%
Cyprus CY 4 3.41 4 3.36 -1.4%
Czech Republic CZ 17 1.60 18 1.69 5.7%
Denmark DK 5 0.90 5 0.90 -0.2%
Egypt EG 16 0.18 17 0.19 4.3%
Estonia EE 2 1.59 2 1.58 -0.6%
Finland FI 15 2.85 15 2.74 -3.8%
France FR 146 2.20 174 2.61 18.7%
Georgia GE 7 1.42 10 2.03 43.0%
Germany DE 670 8.27 250 3.09 -62.6%
Greece GR 16 1.48 16 1.48 0.0%
Hungary HU 13 1.31 14 1.41 7.9%
Iceland IS 1 3.15 1 3.01 -4.4%
Ireland IE 17 3.52 17 3.47 -1.2%
Israel IL 20 2.56 20 2.48 -2.8%
Italy IT 378 6.13 380 6.14 0.2%
Kazakhstan KZ 13 0.72 18 0.99 36.9%
Kosovo XK 0 0.00 1 0.53 N/A
Kyrgyzstan* KGZ 0 0.00 N/A N/A N/A
Latvia LV 2 0.92 2 1.01 9.0%
Lebanon* LB 15 3.63 N/A N/A N/A
Libya* LY N/A N/A N/A N/A N/A
Lithuania LT 3 0.86 3 1.04 21.5%
Luxembourg LU 1 1.92 1 1.75 -8.7%
FYR Macedonia MK 2 0.96 3 1.43 49.7%
Malta MT 1 2.42 1 2.42 -0.3%
Moldova* MD N/A N/A N/A N/A N/A
Montenegro ME 1 1.54 1 1.55 0.5%
Morocco MA 7 0.21 6 0.18 -13.9%
Netherlands NL 31 1.84 29 1.71 -6.8%
Norway NO 10 1.94 9 1.73 -11.0%
Poland* PL 35 0.91 N/A N/A N/A
Portugal PT 24 2.22 26 2.40 8.2%
Romania RO 12 0.55 12 0.55 0.3%
Russian Federation RU 42 0.29 37 0.26 -11.9%
San Marino SM N/A N/A 1 30.28 N/A
Serbia RS 6 0.83 6 0.84 0.5%
Slovakia SK 6 1.09 4 0.74 -32.4%
Slovenia SI 2 1.01 2 1.01 0.2%
Spain ES 130 2.72 130 2.70 -0.8%
Sweden SE 15 1.54 25 2.55 65.3%
Switzerland CH 48 5.95 36 4.43 -25.6%
Syria* SY N/A N/A N/A N/A N/A
Tunisia* TN 8 0.73 N/A N/A N/A
Turkey* TR N/A N/A N/A N/A N/A
Ukraine UA 9 0.20 10 0.23 10.8%
United Kingdom GB 129 2.02 126 1.97 -2.9%
Total ESC countries 1 978 2.13 1 527 1.68 -21.0%
* These 9 countries did not submit any data on CRT implanting centres for the EHRA White Book 2016.
Number of CRT implanting centres 2014 Number of CRT implanting centres 2015
Table 13 Change in the number of total CRT device (CRT-D + CRT-P) implantations in year 2015 vs. 2014
Country ISO code Absolute number Per mil inhabitants Absolute number Per mil inhabitants Change %
Albania* AL  2 1 N/A N/A N/A
Algeria DZ  56 1  108 3 89.3%
Armenia AM  4 1  10 3 150.4%
Austria AT 1 236 150 1 364 157 4.7%
Azerbaijan AZ  18 2  24 2 32.0%
Belarus BY  49 5  100 11 106.4%
Belgium BE 1 332 127 1 485 131 2.9%
Bosnia & Herzegovina BA  23 6  17 4 -26.0%
Bulgaria BG  303 44  296 41 -5.9%
Croatia HR  124 28  261 58 110.8%
Cyprus CY  29 25  30 25 2.0%
Czech Republic CZ 1 872 176 1 952 183 4.1%
Denmark DK  965 173  985 176 1.8%
Egypt EG  530 6  545 6 1.0%
Estonia EE  51 41  73 58 42.3%
Finland FI  526 100  527 96 -3.6%
France FR 9 570 144 10 432 157 8.5%
Georgia GE  55 11  62 13 12.8%
Germany DE 10 378 128 21 139 261 104.0%
Greece GR  580 54  638 59 10.0%
Hungary HU  941 95 1 091 110 16.2%
Iceland IS  26 82  21 63 -22.8%
Ireland IE N/A N/A  319 65 N/A
Israel IL 1 330 170 1 452 180 6.1%
Italy IT 12 336 200 12 815 207 3.6%
Kazakhstan KZ  262 15  314 17 18.5%
Kosovo XK  0 0  4 2 N/A
Kyrgyzstan* KGZ  0 0 N/A N/A N/A
Latvia LV  105 48  107 54 11.1%
Lebanon* LB  160 39 N/A N/A N/A
Libya* LY N/A N/A N/A N/A N/A
Lithuania LT  192 55  195 68 23.4%
Luxembourg LU  34 65  34 60 -8.7%
FYR Macedonia MK  28 13  38 18 35.4%
Malta MT  48 116  41 99 -14.9%
Moldova* MD N/A N/A N/A N/A N/A
Montenegro ME  22 34  19 29 -13.2%
Morocco MA  62 2  84 3 36.1%
Netherlands NL 1 931 114 2 000 118 3.1%
Norway NO  514 100  562 108 8.1%
Poland PL 3 718 97 3 964 103 6.0%
Portugal PT  696 64  772 71 10.8%
Romania RO  289 13  276 13 -4.2%
Russian Federation RU  863 6 1 006 7 16.6%
San Marino SM N/A N/A  2 61 N/A
Serbia RS  321 45  313 44 -2.0%
Slovakia SK  529 96  588 109 12.7%
Slovenia SI  150 75  164 83 9.6%
Spain ES 2 974 62 2 728 57 -9.0%
Sweden SE  854 88 1 034 105 20.1%
Switzerland CH  583 72 1 133 140 92.9%
Syria* SY N/A N/A N/A N/A N/A
Tunisia* TN  180 16 N/A N/A N/A
Turkey TR 2 460 30 2 810 35 17.4%
Ukraine UA  85 2  73 2 -14.4%
United Kingdom GB 9 516 149 10 198 159 6.6%
Total ESC countries 68 912 77 84 205 82 7.5%
* These 7 countries did not submit any data on CRT implantations for the EHRA White Book 2016.
Total CRT implantations 2014 Total CRT implantations 2015
Table 14 Lead extraction facilities and rates in 2015 and comparison to the three previous years
Country ISO code Absolute number Per mil inhabitants Absolute number Per mil inhabitants To attain mean ESC area level To attain mean EU-28 level 2012 2013 2014 2015
Albania* AL N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A
Algeria DZ 3 0.08  41 1.04  507  945 N/A N/A 1 1
Armenia AM 0 0.00  0 0.00  39  73 0 1 0 0
Austria AT 5 0.58  250 28.85 - - 27 30 34 29
Azerbaijan AZ 1 0.10  5 0.51  125  234 N/A 1 1 1
Belarus BY 3 0.32  11 1.16  122  227 4 N/A 1 1
Belgium* BE N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A
Bosnia & Herzegovina BA 0 0.00  0 0.00  50  92 N/A 0 0 0
Bulgaria* BG N/A N/A N/A N/A N/A N/A N/A 2 0 N/A
Croatia HR 5 1.12  49 10.97  57  107 2 0 7 11
Cyprus CY 2 1.68  4 3.36  15  28 0 2 3 3
Czech Republic CZ 6 0.56  300 28.18 - - 29 30 17 28
Denmark** DK 4 0.72 N/A N/A N/A N/A N/A N/A N/A N/A
Egypt EG 3 0.03  20 0.23 1 134 2 114 0 0 0 0
Estonia* EE N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A
Finland** FI 5 0.91 N/A N/A N/A N/A N/A N/A 3 N/A
France FR 30 0.45 3 000 45.08 - - 30 N/A 33 45
Georgia* GE N/A N/A N/A N/A N/A N/A N/A 0 1 N/A
Germany DE 126 1.56 2 357 29.15 - - 10 N/A 61 29
Greece GR 4 0.37  55 5.10  138  257 2 3 5 5
Hungary HU 8 0.81  105 10.61  127  237 7 13 10 11
Iceland IS 0 0.00  0 0.00  4  8 0 0 3 0
Ireland** IE 2 0.41 N/A N/A N/A N/A N/A N/A N/A N/A
Israel IL 5 0.62  80 9.94  103  192 0 N/A 10 10
Italy* IT N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A
Kazakhstan KZ 1 0.06  16 0.88  233  434 0 N/A 0 1
Kosovo* XK N/A N/A N/A N/A N/A N/A N/A N/A 0 N/A
Kyrgyzstan* KGZ N/A N/A N/A N/A N/A N/A 0 N/A N/A N/A
Latvia LV 1 0.50  19 9.56  25  47 3 4 5 10
Lebanon* LB N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A
Libya* LY N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A
Lithuania LT 2 0.69  19 6.59  37  69 3 3 3 7
Luxembourg LU 1 1.75  6 10.52  7  14 18 N/A 13 11
FYR Macedonia MK 2 0.95  1 0.48  27  50 3 0 0 0
Malta MT 1 2.42  9 21.74 -  10 0 0 17 22
Moldova* MD N/A N/A N/A N/A N/A N/A N/A 1 N/A N/A
Montenegro ME 0 0.00  0 0.00  8  15 0 0 0 0
Morocco MA 3 0.09  10 0.30  427  796 0 0 0 0
Netherlands NL 12 0.71  120 7.08  217  405 N/A 24 30 7
Norway NO 3 0.58  194 37.25 - - 36 42 43 37
Poland PL 30 0.78 1 050 27.23 - - 14 12 16 27
Portugal* PT N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A
Romania RO 4 0.18  15 0.69  278  518 0 0 0 1
Russian Federation* RU N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A
San Marino SM 0 0.00 0 0.00 0  1 0 0 N/A 0
Serbia RS 3 0.42  28 3.90  92  171 7 5 9 4
Slovakia SK 3 0.55  119 21.97 -  129 25 20 25 22
Slovenia** SI 1 0.50 N/A N/A N/A N/A N/A N/A N/A N/A
Spain ES 35 0.73  400 8.31  617 1 150 N/A N/A N/A 8
Sweden* SE N/A N/A N/A N/A N/A N/A 22 51 46 N/A
Switzerland** CH 6 0.74 N/A N/A N/A N/A N/A 11 11 N/A
Syria* SY N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A
Tunisia* TN N/A N/A N/A N/A N/A N/A 7 N/A 2 N/A
Turkey TR N/A N/A  420 5.29 1 018 1 898 N/A N/A 4 5
Ukraine UA 6 0.14  45 1.01  569 1 062 1 1 1 1
United Kingdom* GB N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A
Total ESC countries 56  326 0.52 8 748 13 5 6 6 8
* These 17 countries did not submit any data on lead extractions for the EHRA White Book 2016.
** These 5 countries only submitted data on lead extraction centres for the EHRA White Book 2016.
Number of Lead extraction centres 2015 Number of Lead extraction procedures 2015 Development potential - target number of lead extraction procedures Lead extraction procedures per mil inhabitants
Table 15 Catheter ablation facilities and rates in 2015 and in comparison to four previous years
Ablation procedures per mil inhabitants
Country ISO code
National Registry 
for EP Absolute number Per mil inhabitants Absolute number Per mil inhabitants To attain mean ESC area level To attain mean EU-28 level 2011 2012 2013 2014 2015
Albania* AL N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A
Algeria DZ No  3 0.08  303 8 10 259 18 867 N/A N/A 6 6 8
Armenia AM No  3 0.98  48 16  793 1 458 33 23 46 43 16
Austria AT Yes  19 2.19 2 777 320 - 4 135 220 339 294 319 320
Azerbaijan AZ No  5 0.51  398 41 2 538 4 667 20 N/A 24 40 41
Belarus BY No  7 0.74  993 105 2 464 4 532 61 54 76 84 105
Belgium BE No N/A N/A 7 091 626 - - 534 564 580 586 626
Bosnia & Herzegovina BA No  1 0.26 N/A N/A N/A N/A 5 1 0 0 N/A
Bulgaria BG Yes  5 0.70  961 134 1 865 3 429 39 60 54 96 134
Croatia HR No  6 1.34 1 348 302 - 2 130 101 132 183 191 302
Cyprus CY No  3 2.52  60 50  309  567 36 35 39 121 50
Czech Republic CZ Yes  23 2.16 6 158 578 - - 440 474 482 551 578
Denmark DK Yes  6 1.07 3 925 703 - - 457 590 652 694 703
Egypt EG No  15 0.17 1 448 16 22 958 42 221 N/A 11 12 16 16
Estonia EE No  2 1.58  426 337 -  604 300 260 302 327 337
Finland FI No  9 1.64 2 550 466 - 2 613 362 415 418 422 466
France FR No  196 2.94 39 596 595 - - 479 472 N/A 503 595
Georgia GE No  8 1.62  403 82 1 279 2 353 55 75 54 72 82
Germany DE No  346 4.28 63 790 789 - - 614 467 412 741 789
Greece GR Yes  29 2.69 1 710 159 2 796 5 142 130 131 134 153 159
Hungary HU No  11 1.11 3 723 376 - 4 723 293 314 338 350 376
Iceland IS No  1 3.01  78 235  86  158 203 239 254 239 235
Ireland IE No  12 2.45 N/A N/A N/A N/A 214 212 209 N/A N/A
Israel IL No  16 1.99 N/A N/A N/A N/A N/A N/A N/A N/A N/A
Italy* IT No N/A N/A N/A N/A N/A N/A 311 N/A N/A N/A N/A
Kazakhstan KZ No  13 0.72 2 461 136 4 711 8 664 N/A 57 83 112 136
Kosovo* XK No N/A N/A N/A N/A N/A N/A N/A N/A N/A 0 N/A
Kyrgyzstan KGZ No  2 0.35  59 10 1 470 2 703 N/A N/A N/A 10 10
Latvia LV Yes  2 1.01  726 365 -  948 247 269 238 295 365
Lebanon* LB N/A N/A N/A N/A N/A N/A N/A N/A N/A 24 36 N/A
Libya* LY N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A
Lithuania LT No  3 1.04 1 078 374 - 1 376 227 243 239 252 374
Luxembourg LU Yes  1 1.75  145 254  148  272 252 301 251 303 254
FYR Macedonia MK No  2 0.95  166 79  544 1 000 26 30 38 50 79
Malta MT No  1 2.42  32 77  107  198 20 24 29 73 77
Moldova* MD N/A N/A N/A N/A N/A N/A N/A N/A N/A 0 N/A N/A
Montenegro ME No  1 1.55  83 128  168  309 11 149 69 102 128
Morocco MA Yes  5 0.15  60 2 8 646 15 900 3 7 5 5 2
Netherlands NL Yes  16 0.94 8 500 502 - - N/A 382 N/A 495 502
Norway NO No  5 0.96 3 067 589 - - 487 530 507 575 589
Poland PL No  85 2.20 10 795 280 - 18 400 214 229 248 285 280
Portugal PT Yes  25 2.31 2 580 238 2 809 5 165 187 186 191 215 238
Romania RO No  12 0.55 1 194 55 5 621 10 338 50 50 60 62 55
Russian Federation RU Yes  69 0.48 21 482 151 36 953 67 957 118 120 149 168 151
San Marino SM No  0 0.00  0 0  9  16 0 0 0 N/A 0
Serbia RS No  3 0.42  700 98 1 862 3 424 125 133 139 113 98
Slovakia SK Yes  4 0.74 1 204 222 1 405 2 584 177 168 195 202 222
Slovenia SI Yes  3 1.51  712 359 -  946 162 136 140 220 359
Spain ES Yes  80 1.66 12 353 257 12 492 22 973 188 205 253 270 257
Sweden* SE N/A N/A N/A N/A N/A N/A N/A 450 478 465 494 N/A
Switzerland CH Yes  25 3.08 5 709 703 - - 612 598 566 637 703
Syria* SY N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A
Tunisia* TN N/A N/A N/A N/A N/A N/A N/A 56 47 N/A 78 N/A
Turkey TR No N/A N/A 13 000 164 20 604 37 892 N/A N/A N/A 137 164
Ukraine UA No  11 0.25 2 294 52 11 527 21 199 47 55 60 54 52
United Kingdom GB Yes  65 1.01 17 622 275 - 30 579 240 254 251 276 275
Total ESC countries 1 159 1.34 243 808 259 227 217 223 282 289
* These 10 countries did not submit any data on catheter ablations for the EHRA White Book 2016.
Number of ablation centres 2015 Ablation procedures 2015 Development potential - target number of ablation procedures
Table 16 Change in the number of catheter ablation centres in year 2015 vs. 2014
Country ISO code Absolute number Per mil inhabitants Absolute number Per mil inhabitants Change %
Albania* AL  1 0.33 N/A N/A N/A
Algeria DZ  2 0.05  3 0.08 47.2%
Armenia AM  3 0.98  3 0.98 0.1%
Austria AT  17 2.07  19 2.19 6.1%
Azerbaijan AZ  3 0.31  5 0.51 65.1%
Belarus BY  6 0.62  7 0.74 18.0%
Belgium* BE  44 4.21 N/A N/A N/A
Bosnia & Herzegovina BA  0 0.00  1 0.26 N/A
Bulgaria BG  4 0.58  5 0.70 20.4%
Croatia HR  5 1.12  6 1.34 20.2%
Cyprus CY  3 2.56  3 2.52 -1.4%
Czech Republic CZ  22 2.07  23 2.16 4.4%
Denmark DK  6 1.08  6 1.07 -0.2%
Egypt EG  15 0.17  15 0.17 -1.8%
Estonia EE  2 1.59  2 1.58 -0.6%
Finland FI  9 1.71  9 1.64 -3.8%
France FR  130 1.96  196 2.94 50.1%
Georgia GE  7 1.42  8 1.62 14.4%
Germany DE  200 2.47  346 4.28 73.3%
Greece GR  29 2.69  29 2.69 0.0%
Hungary HU  11 1.11  11 1.11 0.2%
Iceland IS  1 3.15  1 3.01 -4.4%
Ireland IE  12 2.48  12 2.45 -1.2%
Israel IL  16 2.05  16 1.99 -2.8%
Italy* IT  0 0.00 N/A N/A N/A
Kazakhstan KZ  9 0.50  13 0.72 42.8%
Kosovo* XK  0 0.00 N/A N/A N/A
Kyrgyzstan KGZ  2 0.36  2 0.35 -1.1%
Latvia LV  2 0.92  2 1.01 9.0%
Lebanon* LB  5 0.85 N/A N/A N/A
Libya* LY N/A N/A N/A N/A N/A
Lithuania LT  3 1.03  3 1.04 1.0%
Luxembourg LU  1 1.92  1 1.75 -8.7%
FYR Macedonia MK  3 1.43  2 0.95 -33.5%
Malta MT  1 2.42  1 2.42 -0.3%
Moldova* MD N/A N/A N/A N/A N/A
Montenegro ME  1 1.54  1 1.55 0.5%
Morocco MA  5 0.15  5 0.15 0.5%
Netherlands NL  16 0.95  16 0.94 -0.4%
Norway NO  5 0.97  5 0.96 -1.2%
Poland PL  83 2.16  85 2.20 1.8%
Portugal PT  24 2.22  25 2.31 4.1%
Romania RO  12 0.55  12 0.55 0.3%
Russian Federation RU  81 0.57  69 0.48 -14.8%
San Marino SM N/A N/A  0 0.00 N/A
Serbia RS  2 0.28  3 0.42 50.7%
Slovakia SK  4 0.73  4 0.74 1.4%
Slovenia SI  3 1.51  3 1.51 0.2%
Spain ES  85 1.78  80 1.66 -6.7%
Sweden* SE  10 1.03 N/A N/A N/A
Switzerland CH  23 2.85  25 3.08 7.9%
Syria* SY N/A N/A N/A N/A N/A
Tunisia* TN  9 0.82 N/A N/A N/A
Turkey* TR  0 0.00 N/A N/A N/A
Ukraine UA  8 0.18  11 0.25 37.1%
United Kingdom GB  61 0.96  65 1.01 6.0%
Total ESC countries 1 006 1.09 1 159 1.34 23.0%
* These 11 countries did not submit any data on ablation centres for the EHRA White Book 2016.
Number of ablation centres 2014 Number of ablation centres 2015
Table 17 Change in the number of catheter ablations in year 2015 vs. 2014
Country ISO code Absolute number Per mil inhabitants Absolute number Per mil inhabitants Change %
Albania* AL N/A N/A N/A N/A N/A
Algeria DZ  240 6  303 8 23.9%
Armenia AM  132 43  48 16 -63.6%
Austria AT 2 622 319 2 777 320 0.5%
Azerbaijan AZ  384 40  398 41 2.6%
Belarus BY  807 84  993 105 24.5%
Belgium BE 6 126 586 7 091 626 6.8%
Bosnia & Herzegovina* BA  0 0 N/A N/A N/A
Bulgaria BG  663 96  961 134 39.7%
Croatia HR  852 191 1 348 302 58.4%
Cyprus CY  142 121  60 50 -58.3%
Czech Republic CZ 5 855 551 6 158 578 5.0%
Denmark DK 3 867 694 3 925 703 1.3%
Egypt EG 1 354 16 1 448 16 5.0%
Estonia EE  411 327  426 337 3.0%
Finland FI 2 222 422 2 550 466 10.4%
France FR 33 300 503 39 596 595 18.4%
Georgia GE  356 72  403 82 13.3%
Germany DE 60 000 741 63 790 789 6.5%
Greece GR 1 653 153 1 710 159 3.4%
Hungary HU 3 469 350 3 723 376 7.6%
Iceland IS  76 239  78 235 -1.9%
Ireland* IE N/A N/A N/A N/A N/A
Israel* IL N/A N/A N/A N/A N/A
Italy* IT N/A N/A N/A N/A N/A
Kazakhstan KZ 2 018 112 2 461 136 20.6%
Kosovo* XK  0 0 N/A N/A N/A
Kyrgyzstan KGZ  58 10  59 10 0.6%
Latvia LV  638 295  726 365 24.0%
Lebanon* LB  150 25 N/A N/A N/A
Libya* LY N/A N/A N/A N/A N/A
Lithuania LT  885 304 1 078 374 23.1%
Luxembourg LU  158 303  145 254 -16.2%
FYR Macedonia MK  105 50  166 79 57.8%
Malta MT  30 73  32 77 6.3%
Moldova* MD N/A N/A N/A N/A N/A
Montenegro ME  66 102  83 128 26.3%
Morocco MA  170 5  60 2 -64.5%
Netherlands NL 8 358 495 8 500 502 1.3%
Norway NO 2 959 575 3 067 589 2.5%
Poland PL 10 922 285 10 795 280 -1.7%
Portugal PT 2 324 215 2 580 238 10.9%
Romania RO 1 358 62 1 194 55 -11.8%
Russian Federation RU 23 874 168 21 482 151 -10.0%
San Marino SM N/A N/A  0 0 N/A
Serbia RS  815 113  700 98 -13.7%
Slovakia SK 1 111 202 1 204 222 9.9%
Slovenia SI  437 220  712 359 63.3%
Spain ES 12 871 270 12 353 257 -4.8%
Sweden* SE 4 803 494 N/A N/A N/A
Switzerland CH 5 135 637 5 709 703 10.4%
Syria* SY N/A N/A N/A N/A N/A
Tunisia* TN  850 78 N/A N/A N/A
Turkey TR 11 218 137 13 000 164 19.1%
Ukraine UA 2 371 54 2 294 52 -3.5%
United Kingdom GB 17 578 276 17 622 275 -0.3%
Total ESC countries 235 793 246 243 808 259 5.7%
* These 12 countries did not submit any data on ablations for the EHRA White Book 2016.
Total ablations 2014 Total ablations 2015
Table 16 Atrial fibrillation ablations in 2015 with comparison to four previous years
AF Ablation procedures per mil inhabitants
Country ISO code Absolute number Per mil inhabitants To attain mean ESC area level To attain mean EU-28 level 2011 2012 2013 2014 2015
Albania* AL N/A N/A N/A N/A N/A N/A N/A N/A N/A
Algeria DZ  0 0 3 814 6 590 N/A N/A 0 0 0
Armenia AM  1 0  295  509 1 3 3 4 0
Austria AT  966 111 - 1 444 62 122 94 107 111
Azerbaijan AZ  6 1  943 1 630 0 N/A 0 0 1
Belarus BY  106 11  916 1 583 4 6 7 7 11
Belgium BE 3 273 289 - - 182 224 225 245 289
Bosnia & Herzegovina BA  0 0  373  644 0 0 0 0 0
Bulgaria BG  147 20  693 1 198 0 7 7 11 20
Croatia HR  385 86  431  744 10 18 38 50 86
Cyprus CY  10 8  115  198 3 5 5 45 8
Czech Republic CZ 2 537 238 - - 156 177 196 216 238
Denmark DK 1 882 337 - - 194 262 290 305 337
Egypt EG  65 1 8 536 14 747 N/A 0 0 1 1
Estonia EE  110 87  122  211 90 27 56 78 87
Finland FI  926 169 - - 91 110 124 140 169
France FR 10 138 152 - 11 091 100 130 N/A 166 152
Georgia GE  64 13  476  822 9 11 7 10 13
Germany DE 33 628 416 - - 184 172 144 494 416
Greece GR  650 60 1 039 1 796 32 37 40 52 60
Hungary HU 1 204 122 - 1 649 61 75 86 109 122
Iceland IS  36 108 -  55 48 77 73 104 108
Ireland IE  650 133 -  815 96 95 94 N/A 133
Israel* IL N/A N/A N/A N/A N/A 0 N/A 70 N/A
Italy* IT N/A N/A N/A N/A N/A 0 N/A N/A N/A
Kazakhstan KZ  762 42 1 751 3 026 6 11 15 29 42
Kosovo* XK N/A N/A N/A N/A N/A N/A N/A 0 N/A
Kyrgyzstan* KGZ N/A N/A N/A N/A N/A N/A N/A N/A N/A
Latvia LV  88 44  192  331 31 26 29 35 44
Lebanon* LB N/A N/A N/A N/A N/A N/A N/A N/A N/A
Libya* LY N/A N/A N/A N/A N/A N/A N/A N/A N/A
Lithuania LT  81 28  278  481 19 8 9 21 28
Luxembourg LU  48 84  55  95 54 61 60 109 84
FYR Macedonia* MK N/A N/A N/A N/A 0 0 0 0 N/A
Malta MT  0 0  40  69 0 0 2 0 0
Moldova* MD N/A N/A N/A N/A N/A N/A 0 N/A N/A
Montenegro ME  18 28  62  108 0 0 0 26 28
Morocco* MA N/A N/A N/A N/A 0 0 N/A N/A N/A
Netherlands NL 3 600 212 - - N/A 156 N/A 202 212
Norway NO 1 460 280 - - 242 249 293 278 280
Poland PL 3 253 84 3 720 6 427 N/A 44 50 57 84
Portugal PT  743 69 1 044 1 804 43 49 51 63 69
Romania RO  132 6 2 090 3 611 3 4 6 4 6
Russian Federation RU 6 329 44 13 739 23 735 27 27 41 45 44
San Marino SM  0 0  3  6 0 0 0 N/A 0
Serbia RS  150 21  692 1 196 8 14 17 33 21
Slovakia SK  224 41  522  903 17 18 27 23 41
Slovenia SI  214 108 -  331 59 55 83 75 108
Spain ES 2 426 50 4 644 8 024 31 33 46 52 50
Sweden* SE N/A N/A N/A N/A 157 178 179 184 N/A
Switzerland CH 1 991 245 - - 209 193 184 209 245
Syria* SY N/A N/A N/A N/A N/A N/A N/A N/A N/A
Tunisia* TN N/A N/A N/A N/A 2 3 N/A 4 N/A
Turkey TR 2 200 28 7 660 13 235 N/A N/A N/A 15 28
Ukraine UA  634 14 4 286 7 404 11 14 15 14 14
United Kingdom GB 6 390 100 - 10 681 74 80 85 102 100
Total ESC countries 56 87 527 123  66  69  72  122  123
* These 13 countries did not submit any data on AF ablations for the EHRA White Book 2016.
AF Ablation procedures 2015 Development potential - target number of AF ablation procedures
Table 19 Change in the number of catheter ablations of AF in year 2015 vs. 2014
Country ISO code Absolute number Per mil inhabitants Absolute number Per mil inhabitants Change %
Albania* AL N/A N/A N/A N/A N/A
Algeria DZ  0 0  0 0 0.0%
Armenia AM  11 4  1 0 -90.9%
Austria AT  878 107  966 111 4.4%
Azerbaijan AZ  2 0  6 1 197.1%
Belarus BY  69 7  106 11 55.4%
Belgium BE 2 560 245 3 273 289 18.0%
Bosnia & Herzegovina BA  0 0  0 0 0.0%
Bulgaria BG  79 11  147 20 79.3%
Croatia HR  223 50  385 86 72.9%
Cyprus CY  53 45  10 8 -81.4%
Czech Republic CZ 2 297 216 2 537 238 10.3%
Denmark DK 1 698 305 1 882 337 10.6%
Egypt EG  60 1  65 1 6.4%
Estonia EE  98 78  110 87 11.6%
Finland FI  736 140  926 169 21.0%
France FR 11 000 166 10 138 152 -8.2%
Georgia GE  50 10  64 13 28.1%
Germany DE 35 000 432 33 628 416 -3.8%
Greece GR  560 52  650 60 16.1%
Hungary HU 1 081 109 1 204 122 11.6%
Iceland IS  33 104  36 108 4.3%
Ireland IE N/A N/A  650 133 N/A
Israel* IL  550 70 N/A N/A N/A
Italy* IT N/A N/A N/A N/A N/A
Kazakhstan KZ  524 29  762 42 43.8%
Kosovo* XK  0 0 N/A N/A N/A
Kyrgyzstan* KGZ N/A N/A N/A N/A N/A
Latvia LV  75 35  88 44 27.9%
Lebanon* LB N/A N/A N/A N/A N/A
Libya* LY N/A N/A N/A N/A N/A
Lithuania LT  74 25  81 28 10.6%
Luxembourg LU  57 109  48 84 -23.1%
FYR Macedonia* MK  0 0 N/A N/A N/A
Malta MT  0 0  0 0 0.0%
Moldova* MD N/A N/A N/A N/A N/A
Montenegro ME  17 26  18 28 6.4%
Morocco* MA N/A N/A N/A N/A N/A
Netherlands NL 3 413 202 3 600 212 5.0%
Norway NO 1 432 278 1 460 280 0.8%
Poland PL 2 169 57 3 253 84 49.1%
Portugal PT  684 63  743 69 8.5%
Romania RO  88 4  132 6 50.4%
Russian Federation RU 6 462 45 6 329 44 -2.0%
San Marino SM N/A N/A  0 0 N/A
Serbia RS  236 33  150 21 -36.1%
Slovakia SK  129 23  224 41 76.1%
Slovenia SI  149 75  214 108 44.0%
Spain ES 2 498 52 2 426 50 -3.7%
Sweden* SE 1 791 184 N/A N/A N/A
Switzerland CH 1 684 209 1 991 245 17.4%
Syria* SY N/A N/A N/A N/A N/A
Tunisia* TN  40 4 N/A N/A N/A
Turkey TR 1 208 15 2 200 28 87.2%
Ukraine UA  622 14  634 14 1.6%
United Kingdom GB 6 505 102 6 390 100 -2.3%
Total ESC countries 86 895 93 87 527 96 3.2%
* These 7 countries did not submit any data on AF ablations for the EHRA White Book 2016.
AF Ablation procedures 2014 AF Ablation procedures 2015
